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Abstract
This study assessed the association between early severity of epilepsy and subsequent
depressive symptoms in youth and the extent to which family and clinical factors
mediated this relationship. Data were obtained from the Health-Related Quality of Life in
Children with Epilepsy Study, a multi-centre prospective study of children with newonset epilepsy. A multiple linear regression analysis revealed severity of epilepsy 2 years
post-diagnosis to be positively associated with depressive symptoms 10 years postdiagnosis (b=2.10, 95%CI:0.42,3.79). The results of generalized estimating equation
models found family functioning, family resources, parental depressive symptoms, and
antiepileptic drug use to not be mediators. Five-year seizure freedom mediated this
relationship (ab=1.22, 95%CI:0.35,2.09), decreasing the magnitude of the total effect of
severity of epilepsy on depressive symptoms by 58%. These findings provide insight on
long-term effects of the early clinical presentation of epilepsy. Clinical efforts to achieve
remission may be targeted to reduce risk of depressive symptoms.
Keywords: Childhood epilepsy, Depressive symptoms, Adolescents, Young adults,
Family environment, Longitudinal study
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Chapter 1
1

Introduction

This thesis examines the relationship between overall early severity of epilepsy during
childhood as a predictor of subsequent depressive symptoms during adolescence and
early adulthood. Moreover, it explores whether aspects of the family environment and
proximal clinical factors play a part in the pathway of this relationship. Clarifying the role
of familial and clinical factors on the risk of depressive symptomology will inform
researchers and clinicians of potential targets to implement interventions. This may
ultimately provide an opportunity to lower the risk of depression by targeting family
factors of youth who may have had severe epilepsy during their childhood.
This chapter will provide background information regarding epilepsy and
introduce the burden of depression in youth who are living with epilepsy.

1.1

Background

1.1.1 Epilepsy Overview
Epilepsy is a neurological condition characterized by a predisposition to recurrent
epileptic seizures (1). To be diagnosed with epilepsy, a person must fit at least one of the
following criteria: 1) two or more unprovoked seizures occurring 24 hours apart; 2) one
unprovoked (or reflex) seizure and a probability of further seizures similar to the general
reoccurrence risk (at least 60%) after two unprovoked seizures, occurring over the next
10 years; or 3) diagnosis of an epilepsy syndrome (1). The International League Against
Epilepsy’s (ILAE) classification includes three major categories of seizures: focal (motor
or non-motor), generalized (motor or absence), or unknown onset (motor or non-motor)
(1). Seizure type is based on the origin of seizures in the brain and are useful for
communication purposes in clinical care and research (2,3). Generalized seizures
originate from large areas of the cortex in both hemispheres, whereby focal seizures,
formally referred to as partial seizures, arise from small loci of the cortex in only one
hemisphere and may originate in subcortical structures (2). There is almost always a loss
of consciousness associated with generalized seizures; however, in the case of focal
seizures, impaired awareness may or may not occur (2). It is possible for patients to
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outgrow their epilepsy, especially for those with childhood-onset mesial temporal lobe
epilepsy who had their hippocampal sclerosis resected (1). For epilepsy to be considered
resolved, a person must be seizure-free for at least a decade and not have taken
antiepileptic drugs (AED) for the past five years or be past the applicable age for their
age-dependent epilepsy (1). There is no formal definition for epilepsy being in remission,
however experts have proposed that five years of seizure freedom and two years off
seizure medication be used due to the modest differences in relapse rates between these
time points and that of the criteria for epilepsy being resolved (4).
The primary medical treatment received by the majority of people who have
epilepsy is drug therapy in the form of antiepileptic drugs. AEDs provide good seizure
control for 65% of patients with new-onset epilepsy (5). Over a year, AEDs completely
eliminate seizures in 50% of new-onset patients, and reduce the frequency of seizures in
17% of people, leaving nearly 33% of AED users with uncontrolled seizures (5).
Approximately 30% to 40% of patients do not achieve full control over their seizures
with a single AED, and their neurologists must experiment with different AEDs or
combinations of AEDS to gain seizure control (5–7). Some patients experience drugresistant epilepsy and may be candidates for surgery. Resective surgery involves removal
of the localized epileptogenic tissue, and has been found to control seizures in 64% to
70% of drug-resistant temporal lobe epilepsy patients alongside AED treatment (5,8).
Prior to attempting surgery or when surgery fails, vagus nerve stimulation is a noninvasive palliative treatment option that has been proven to be effective for people who
have refractory focal onset-epilepsy (9).

1.1.2 Childhood-Onset Epilepsy
There are many possible causes of childhood-onset epilepsy. It may have a genetic or
molecular basis, occur post-infection or following an acute brain injury, or be due to
abnormalities of cortical development, neurocutaneous disorder or hippocampal sclerosis
(10). Although the majority of children reach remission, 13% to 17% of patients have
refractory (intractable) epilepsy which is often associated with a poor prognosis (10). A
large portion of patients (30%) have pharmacosensitive epilepsy for which they achieve
good seizure control and may have a spontaneous remission after a few years.
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Pharmacodependent epilepsy requires individuals (20%) to take their medication but they
do not achieve remission. Lastly, people with benign epilepsies may never require
treatment and achieve remission after a few years (10).
Over three quarters of children with idiopathathic (no apparent cause) epilepsy,
the most common form, are expected to be in remission by two years following diagnosis
(11). Children who continue to have frequent seizures during the first year of treatment
are at an increased risk of developing intractable epilepsy and never achieving one-year
terminal remission (12). Seizure frequency is negatively correlated with epilepsy
outcomes because it is ultimately reflective of severity of epilepsy (13).

1.1.3 Prevalence of Epilepsy
Globally, 10.5 million children up to the age of 14 are living with epilepsy, which
constitutes 25% of all cases (14). The prevalence of childhood epilepsy ranges from 3 to
7 per 1000 people in developed countries, as compared to 9 to 22 per 1000 people in
developing countries (15). The higher prevalence of epilepsy in developing countries may
be attributed to parasitic infections, a common cause of epilepsy in these countries (15).
The incidence of epilepsy in Nova Scotia, Canada was found to decrease with age, at 118
per 100,000 children under the age of 1, 48 per 100,000 for children between the ages of
1 to 5 years, 43 per 100,000 for children aged 6 to 10 years, and 21 per 100,000 for
children aged 11 to 15 (16). For children and youth up to the age of 19, the prevalence of
epilepsy has been estimated to be 4.7 per 1000 people in Manitoba, Canada, with the
highest prevalence in those aged 15 to 19 years (7.19 per 1000 people) and the lowest
among children under the age of 9 (17). From two Canadian population based studies, the
prevalence of epilepsy among adolescents aged 12 to 14 years was estimated to be 2.9 to
4.4 per 1000 people, and for youth aged 15 to 24 years, 4.8 to 3.6 per 1000 people (18).
The estimated median number of people with lifetime epilepsy in developed
countries is 6.8 million of which 84% are active cases (19). In developing countries it is
much higher at 45 million for rural areas and 17 million for urban areas of which,
respectively, 38% and 59% are active cases (19). For people of all ages, the prevalence of
self-reported epilepsy in Ontario has been estimated to be 5.8 per 1000 people (20). Also
in Ontario between the years of 2004/05 and 2010/11, the prevalence of epilepsy has
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increased from 63,898 cases to 89,867 cases (21). Among adults, the prevalence
estimates for active epilepsy in Canada range from 5 to 10 per 1000 people (22). Reports
from two Canadian population surveys indicate a significantly higher prevalence of
people with self-reported epilepsy among those who have a low educational attainment
and income and those who are unemployed (18). This is consistent with a recent study in
the United Kingdom where epilepsy was more common in the those who had less
education, lower income, and were less satisfied with their employment (23).

1.2

Depression in Adolescents and Young Adults with Epilepsy

Adolescence may be a difficult stage in life due to the rapid physical, social, and
psychological development that occurs during this period (24). For youth with epilepsy, it
may be more challenging as they try to gain independence from their parents and
transition into being responsible for the management of their medical condition.
Additionally, these youth continue to cope with epilepsy-related stigma and limitations
that the disease may have placed affecting their social and physical functioning (24,25).
The occurrence of puberty during early adolescence is a time where the frequency of
seizures may be altered, depending on seizure type, thereby potentially changing the
severity of their epilepsy (26). Some concerns expressed by adolescents living with
epilepsy have been related to education/career options, potential effects of discontinuing
AEDs, being eligible to drive, and leisure activities and alcohol use (27). A third of
children and teenagers with epilepsy expect the disease to hinder their lives in the future,
with the most commonly perceived problems being regarding employment opportunities
(73%), travelling and exploring (37%), and education (36%) (28). Among teenagers
without epilepsy, a 2001 survey of high school students found that half were not sure if
people with epilepsy (PWE) could drive cars, work, or should have children, a third
indicated that they would not date a person who has epilepsy, and 63% thought that youth
with epilepsy were likely to get bullied (29). Accordingly, along with coping with the
daily struggles of growing up with epilepsy and worrying about their future, adolescents
may have to deal with being treated differently by their peers.
Depression is a mood disorder that may present with a loss of energy, feelings of
guilt, difficulty concentrating, hopelessness, or thoughts of suicide (30). The incidence of
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depression in adolescents tends to increase with age, peaking in late adolescence/early
adulthood (31,32). As adolescents mature into young adults there may be new pressures
with becoming of legal age for alcohol and tobacco use, achieving higher levels of
education, beginning occupations, or even marriage. Thus, it is not surprising that
adolescents and young adults tend to have a higher prevalence of depression as compared
with children (33). A study examining the temporality of mental health disorders in the
United States found that 75% of adults with a mental health disorder had an age of onset
before 24 years (34). In the year 2011, an estimated one million Canadian youth were
living with a mental illness, and this is expected to increase to 1.2 million by the year
2041 (35).
Depression may be more problematic for youth with chronic health diseases
such as epilepsy due to the added stress of the disease with regular life stage stressors.
Unfortunately, many cases of mild and moderate depression among PWE go
unrecognized and under-diagnosed by physicians due to the depressive and anxiety
symptoms being assumed to be a reflection of the normal adaptation process to epilepsy
(36). Symptoms of depression including decreased concentration, fatigue, and sleep
disturbances are also mutual side effects of AEDs (37). Therefore, it is essential to
closely monitor the mental health of youth with epilepsy. Factors predictive of
psychopathology in PWE are multifactorial [epilepsy disease and treatment-related,
psychosocial (including familial factors), and demographic] (38). The possible causes of
depression include: the endocrine and/or metabolic effects of seizures, common
pathogenic mechanisms between the two conditions, adverse effects of various AEDs,
and or the psychological response to having epilepsy due to its mental, physical and
social challenges (39). Depressive symptoms occurring in PWE can be categorized as
either ictal (symptoms are a clinical manifestation of a seizure), peri-ictal (symptoms
precede and or/occur following the seizure) and interictal (symptoms occur independent
of the seizures) (40). Interictal depression is the most common and can present as minor
or major depression, dysthymic disorder, or bipolar disorder (40).

1.2.1 Prevalence of Depression in People with Epilepsy
The Canadian Community Health Survey 2000/2001 cycle found the prevalence of
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depression to be significantly higher (13%) among people over the age of 12 living with
epilepsy as compared to those without epilepsy (7.2%) (41). In Alberta, the prevalence of
depression among PWE of all ages was 28.2% based on administrative health data (42).
For Canadians over the age of 15 years with epilepsy, the lifetime prevalence of a major
depressive disorder was 17.4% in 2002 (43). The U.S. HealthyStyles 2004 survey
produced results consistent with Canadian studies where adults ever diagnosed with
epilepsy were 2.5 times more likely to self-report depression in the previous year as
compared to people without epilepsy, after controlling for demographic factors (32.6%
vs. 15.5%) (44). Although a larger proportion of people with active epilepsy self-reported
depression compared to people with inactive epilepsy (39.7% vs. 23.8%), the difference
in the likelihood of having depression between the two groups was not statistically
significant (44). This suggests that the current state of epilepsy may not be the only
predictor of psychiatric problems in this population, but perhaps common past or current
biological or psychosocial mechanisms are also of importance.

1.2.2 Implications of Depression for People Living with Epilepsy
Depression is one of the most prevalent psychiatric illnesses among PWE with the
possibility of the relationship being bidirectional (40). A few studies have found people
with past depressive disorders to be at an increased risk of developing seizures. However,
it may not be the case that depression causes epilepsy but rather there are common
pathologic mechanisms responsible for the co-occurrence of these two conditions (40).
The primary focus of research in this field is how depressive disorders develop in those
diagnosed with epilepsy leading to negative implications on their quality of life.
For the general public in 1998, the economic burden associated with depression
and distress in Canada was estimated to be $278 million attributed towards direct costs
due to psychologist and social worker visits and $6.02 billion for indirect costs due to
missing work (45). Among children and youth, ages 10 to 24 years residing in Ontario,
there has been a relative increase of 32.5% in mental health-related emergency
department visits, 15.8% in office-based physician visits, and 53.7% in hospitalizations
between 2006 and 2011 (46). Moreover, early adolescent depression has been found to
increase the risk of having poorer self-perceived general health, increased health care
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utilization, and increased work impairment during early adulthood while controlling for
concurrent depression (47). Also in Ontario in 2010/11, the average costs of health
systems use among prevalent and incident cases of epilepsy were $7283 and $10,631,
respectively (21). The majority of these costs were attributed to hospital care, physician,
and other health care professional services, and long-term or home care. PWE were also
found to be four times more likely to be hospitalized for depression compared to those
without epilepsy (48). Thus, untreated depression among PWE is likely to increase the
use of healthcare resources with a greater need of resources for individuals with severe
symptoms (49).
Early detection and treatment are exceptionally important among PWE due to the
risk of untreated depression possibly interfering with condition self-management
behaviours, leading to poor health outcomes (50,51). Non-adherence to AEDs is more
common among depressed epilepsy patients, and the presence of co-morbid depression
has also been found to be associated with a lack of response to AEDs (52–54). The
occurrence of major depression may also affect the clinical course of epilepsy, with
patients experiencing more difficulty with the cognitive, emotional, and physical aspects
of recovering from a seizure (55).
Untreated depression in adolescents is associated with a high risk of self-harm and
suicide, with more than half of suicides having a history of depression (56,57). The
average incidence of suicide is 10-fold higher among patients with epilepsy as compared
to the general public (40,58). In Canada, the lifetime prevalence of suicidal thoughts in
PWE is significantly higher compared to people without epilepsy (25% vs. 13.3%) (43).
A higher rate of death by suicide is also present among those with epilepsy (5% vs. 1.4%)
(59). The high risk of suicide among epilepsy patients may be related to common
mechanisms associated with the development of both major depression and epilepsy, as
both a history of attempted suicide and major depression have been found to be
associated with the development of unprovoked seizures (60).
Untreated depression may also have substantial implications on the health-related
quality of life (HRQoL) of people living with epilepsy. HRQoL, a construct referring to
the “subjective and objective impact of dysfunction associated with an illness or injury,
medical treatment, and health care policy”, is considered the most important health
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outcome with respect to chronic health conditions by the ILAE Commission (61,62).
Previous research has found patients’ HRQoL to be more strongly associated with mood
states as compared to severity and frequency of seizures (63,64). Additionally, depressive
symptoms have been shown to be associated with poor HRQL regardless of seizure type
among adults (55). A strong linear relationship has been found to exist between
depressive symptoms and HRQoL, with more symptoms being associated with lower
HRQoL scores (64). Among adults, depression accounts for 30% to 35% of the variance
is HRQoL, whereby demographic and clinical factors only account for 15% to 20% (64).
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Chapter 2
2

Literature Review

This chapter provides an overview of prior literature on the severity of epilepsy as a risk
factor for depression and the importance of family environment for patients. Studies were
located by searching the following electronic databases: PsychINFO, Pubmed
(MEDLINE), and CINAHL. Furthermore, the ancestry method was implemented to
identify studies that were not found in the initial searches by locating additional articles
through reviewing the reference lists of studies.
The first two sections review literature on the relationship between severity of
epilepsy and other clinical factors with depression (Sections 2.1-2.2). Sections 2.3-2.5
review literature on the association between family factors and depression in patients
with epilepsy. The final section (Section 2.6) presents an overview of the limitations
characterizing the literature to date.

2.1

Severity of Epilepsy

Severity of epilepsy encompasses all aspects of the disease, incorporating both clinical
features, such as frequency and severity of seizures, and its level of disruptiveness to the
patient’s functioning, such as falls or injuries during seizures and side effects or
interference of drugs with daily activities (65,66). Difficulty with seizure control is likely
to be associated with lifestyle restrictions and negative consequences on patients’ mental
health (67,68). Thus, physicians aim to manage disease severity over time to reduce the
risk of side effects and improve long-term outcomes through the use of treatments and/or
by recommending interventions.

2.2

Early Childhood Severity of Epilepsy and Depression

Living with a chronic childhood illness such as epilepsy may have implications on mental
health during adulthood. Youth and adults with childhood epilepsy experience more
psychiatric disorders, irrespective of seizure mediation use or having gained full seizure
control, as compared to the general public (69–71). This is not surprising given that
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several childhood chronic conditions have been found to be associated with psychiatric
problems and lower quality of life in adulthood (72). With regards to epilepsy, it is
unknown whether the disease itself is the root of unfavourable adulthood outcomes, or
whether unfavourable outcomes are due to consequences and side effects of illness, such
as modifications in the family environment.
The time around the diagnosis of a disease is a difficult period for both the child
and family. Over time, once the condition becomes chronic, the long-term impact of the
condition is perceived to be greater due to the prolonged stress (73). Following diagnosis,
the state of a disease may change for the better, become worse, or remain stable over
time. The effect that the disease may have on long-term psychological and physical stress
may depend on whether the disease is quickly managed and creates minimal disruptions,
as compared to a chronic course of illness with a greater burden (73).
Although epilepsy is a chronic disease, the majority (65%) of children diagnosed
gain full control of their seizures using medications within the first two years and may
discontinue treatment (74). As a general rule of thumb for children with a promising
prognosis, physicians recommend discontinuing AED treatment after one to two years of
seizure freedom (74–76). The remaining children who do not gain seizure control within
the early years following diagnosis are the ones at risk of having retractable epilepsy (77).
Specifically, those whose seizures do not remit within two years of AED use (35%) are
unlikely to ever be seizure free for life without an intervention (74). As such, the severity
of epilepsy a few years after diagnosis is likely a better predictor of long-term course, as
the disease prognosis becomes apparent by this time.
Severity of epilepsy has not yet been tested prospectively as a risk factor for
depression, but more severe seizures and epilepsy have been found to be associated with
depression, emotional problems, internalizing problems, self-concept, and self-esteem
when measured cross-sectionally (78–81). Among individual clinical factors, seizure
frequency appears to contribute the most to ratings of severity of epilepsy (65). During
the early stages of the disease, having frequent seizures has been found to be associated
with depression in adolescents with varying disease durations (82,83). Thus, the
exploration of severity of epilepsy in the early years of the disease as a risk factor for
subsequent depression among young people with childhood-onset epilepsy seems
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warranted. Sections 2.2.1 to 2.2.5 are a review of the clinical features of epilepsy
(severity of seizures, frequency of seizures, AED use, seizure type, duration of epilepsy,
and age of onset) indicative of severity of epilepsy that have been found to be associated
with depression.

2.2.1 Severity of Seizures and Poor Seizure Control
Severity of seizures and severity of epilepsy are highly interrelated and are occasionally
incorrectly used interchangeably. The severity of seizures is only one of several
determinants of overall severity of epilepsy. Severe seizures may be difficult to control so
may lower autonomy, have psychosocial implications, and decrease quality of life
(84,85). As such, severity of seizures has been a well-studied risk factor for depression in
people diagnosed with epilepsy (78,84,86–88). A population-based study in the UK of
children and adolescents with epilepsy has been the only one to find increasing seizure
severity to be independently associated with a higher risk of depression (OR= 1.09, 95%
CI =1.01 to 1.17) (78). The mean age of epilepsy onset within this group was 6 (SD:
4.83) years and all participants were prescribed antiepileptic medication within the last
six months. Due to the cross-sectional nature of the study, the direction of the relationship
between increased seizure severity and depression cannot be determined.
Lack of seizure control is more common in those with more severe seizures and
has been found to be associated with the risk of depression in a small number of studies.
Among adults (n=300), effective seizure control was associated with a reduced risk of
depression, measured using the Hospital Anxiety and Depression Scale (HADS) (89).
Moreover, uncontrolled seizures posed a 2-fold increase in the risk of having major
depression in 15 to 85-year-old epilepsy patients (n=298) (90). Consistent findings were
obtained for a similar outcome of major depressive disorder (MDD) for children and
adolescents (91). The participants (n=174) in this study had a mean onset of epilepsy of
5.6 years and were prescribed AEDs for a minimum of 6 months prior to study
enrollment. MDD was assessed using the Schedule for Affective Disorder and
Schizophrenia for School Age Children: Present and Lifetime Version.
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2.2.2 Frequency of Seizures
Experiencing frequent seizures while using AEDs is an indicator of poor seizure control
and worse disease severity, making it a potential risk factor for psychosocial
consequences. A high frequency of seizures has been found to be associated with a
number of psychiatric problems including depression, anxiety, low self-esteem, and
stressful life experiences (92–96). Although the findings of seizure frequency being a risk
factor for depression are mixed (87,88,97–99), a large number of studies have reported
that the two variables are significantly related (82,83,90,91,100–106).
The definition used to classify frequent seizures is highly variable among studies,
ranging from experiencing seizures on a daily basis to experiencing any seizure in the
past week, month, or year. One study compared the frequency of seizures that people
over the age of 16 (n=440) had in the past 2 years (none, once, more than once but not
monthly, monthly to weekly, at least weekly) and found this to be the only epilepsyrelated risk factor for depression, measured using the Center for Epidemiological Studies
Depression Scale (CES-D) (100). A key limitation that may explain the lack of
associations between other epilepsy-related variables and depressive symptoms is that
participants reflected only those who attended a primary care clinic potentially underrepresenting severe cases.
Having seizures more than once per month more than doubled the risk of
depression in a study of adults with epilepsy (101). However, this study did not include
all seizure types; specifically, people experiencing tonic, atonic, clonic, or atypical
absence seizures were excluded. Adults who experienced one to three seizures monthly
were approximately four times more likely to have depression compared to those who did
not have a seizure every month (102). Among adolescents with childhood-onset epilepsy,
the frequency of seizures in the preceding month was the best predictor of depressive
disorders and also of anxiety, measured using the Diagnostic Interview for Children
Version IV (103). Another more recent study obtained consistent findings, however their
outcome of interest was exclusively MDD (91). Youth with seizures occurring more than
once a week were also more likely to have an episode of MDD compared to youth with a
lower frequency of seizures. Furthermore, a study found that patients who had a seizure
at least once a week were three times more likely to have depression, assessed
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using the HADS, as compared to patients who were free of seizures for the past year
(104).
Seizures in the past six months were defined as frequent seizures among studies
with exclusively adult participants. Having at least one seizure in the past six months was
associated with a high risk of depression (RR= 1.39, 95% CI=1.12 to 1.74), assessed
using the Hamilton Depression Scale, for women between the ages of 18 to 55 years
(105). Additionally, a two-fold increase in the Neurological Disorders Depression
Inventory for Epilepsy score was found among adults with epilepsy who reported at least
one seizure in the past six months as compared to those with no seizures (90). Using the
Patient Health Questionnaire-9 to assess depression, another study found that adults with
seizures in the past six months with a loss of consciousness had a higher risk of
depression (OR=5.60, 95% CI= 2.54 to 12.77) compared to those with no loss of
consciousness (OR= 2.22, 95% CI= 1.06 to 4.66) (n=80 cases and 141 controls) (106).
Among children and adolescents, a high frequency of seizures close to epilepsy
onset has also been examined as a risk factor of future depression. Among children
(n=25) with idiopathic epilepsy and a disease onset before 15.6 years, Children’s
Depression Inventory (CDI) scores were higher in those with daily seizures than those
who had one seizure or were seizure free after using AEDs in the early stages of the
disease (83). Among adolescents (n=140) with an epilepsy onset between the ages of 0.3
and 17 years, frequent seizures (weekly or daily) at the time of onset were associated with
the risk of having depression (OR=3.52, 95% CI=1.51 to 8.17, p =0.003), assessed using
the HADS (82).

2.2.2.1

Seizure Remission

Although epilepsy is an incurable but controllable disease, researchers sometimes classify
patients as being in remission and or having inactive epilepsy if they have been seizure
free for years to reduce disease-related stigma (1). There have been varying definitions of
how many years of seizure freedom are required to be in remission with some proposing
that it should be five years (107). Being in remission is different, however, from epilepsy
being ‘resolved’. In the 2017 ILAE guidelines, a patient’s epilepsy is considered resolved
if he/she had age-dependent epilepsy and are now past the applicable age or if the patient
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has been free of seizures for the past 10 years and has not used an AED in the last 5 years
(108).
Although it is assumed that gaining remission would reduce the likelihood of
epilepsy-related stigma, this is not always the case (109). A prospective study that
followed adolescents for eight to nine years after diagnosis of childhood-onset epilepsy
found gaining remission (five years of seizure freedom) was not associated with childreported health related quality of life but rather having a psychiatric illness was of greater
importance (110). However, among this same cohort of adults, five years of seizure
freedom was associated with a greater proportion of people reporting internalizing
disorders (111). Among Canadian adults, experiencing even a single seizure in the past
five years has been found to lead to a six-times greater odds of having depression as
compared to those who achieved five-year seizure freedom (112). Failure to achieve fiveyear seizure freedom was also associated with a greater risk of being unable to drive;
experiencing limitations for education, employment, and activities of daily living; and
having greater self-perceived stigma (112). Seizure remission has also been found to
reduce illness intrusiveness and the severity of subjective handicap that epilepsy places
on patients’ daily activities (113,114). One study that classified adults as being in
remission if they had not experienced a seizure in the past year found that 4% of people
in this group had depression as compared to 17% of people with active epilepsy. This
trend was also apparent with anxiety where 28.9% of people with active epilepsy had
anxiety as compared to 12.4% of people in remission (115). Alternatively, one study
found neither seizure freedom nor any other epilepsy-related clinical factor to be
associated with psychiatric disorders (116). Gaining seizure remission was also not found
to effect social outcomes, but rather having a mental handicap and/or learning disorders
were more influential (117).

2.2.3 Antiepileptic Medication
Antiepileptic drugs (AEDs) may exhibit mood-altering properties and thus, have been
examined as risk and protective factors for mental illnesses (118). Occasionally, patients
with less severe epilepsy do not require AEDs, others experiment with different
combinations to gain full control of their seizures, and a select few are unsuccessful at
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controlling their seizures with AEDs (119). Drug responsiveness has been found to
decrease the risk of major depression among adults (OR=0.23, p<0.01), measured using
the Diagnostic and Statistical Manual of Mental Disorders and confirmation from a
hospital psychologist (120). Non-compliance to medication may be a problem area for
people with depression as there is a higher occurrence of MDD in patients with poor
medication adherence as compared to those with high or medium adherence rates (91).
The presence of side effects of AEDs is also associated with depression, assessed using
the HADS, among adults (n=1069) with epilepsy (92). Participants who experience
medication side effects are approximately three times more likely to experience
depression (AOR=3.07, 95% CI= 1.80 to 5.21) as well as anxiety (AOR=2.51, 95% CI=
1.60 to 3.94) (104).
The majority of studies have reported that AED type is not correlated with
depression (97). Nonetheless, a small number of studies reported an association between
these two factors, each with different AEDs being problematic. The AED lamotrigine has
been found to decrease the likelihood of being depressed (OR=0.4, 95% CI= 0.2 to 0.8)
among adults from a tertiary care centre (106). Alternatively, phenobarbital has been
found to be associated with a higher risk of depression among children who had a family
history of depression (121). Oxcarbazepine use, which was found to be correlated with
frequent seizures, polytherapy treatment, and complex partial seizures has been found to
be associated with an increased risk of depression as compared to other AEDs (OR= 2.26,
95% CI=1.04 to 4.90) (101). This study further explored the effect of drugs by grouping
together medications thought to have depression-inducing properties, including
hormones, β-blockers, calcium antagonists, interferons, and some antiparkinsonian drugs,
and found depressogenic medications to be related with a risk of depression in PWE
(OR= 3.33, 95% CI= 1.50 to 7.39, p=0.003).

2.2.3.1

Monotherapy vs. Polytherapy

In more severe cases of epilepsy, the use of a single AED (monotherapy) is not sufficient
to control seizures and multiple AEDs (polytherapy) are required (119). The findings on
whether the use of more than one AED places PWE at greater risk of developing
depression are inconclusive (122–124). Among adults who had childhood epilepsy, a
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history of failing to achieve seizure control from two or more AEDS was not associated
with psychiatric illnesses (111). The majority of studies, however, found monotherapy to
be the safer treatment option with regards to the risk of psychopathology. Nonetheless,
when seizures cannot be controlled with only one AED, polytherapy treatment is
unavoidable. In a systematic review, four studies were identified where polytherapy was
significantly associated with higher depression scores in children and adolescents, with
one study finding them to be associated with the following domains of the CDI:
interpersonal problems, ineffectiveness, and negative self-esteem (122). The findings are
consistent in adults with one study showing almost a two-times greater risk of depression
with polytherapy treatment (COR= 1.76, 95% CI= 1.11 to 2.78) as compared to
montherapy treatment (90,94,102). Another study found that a higher number of people
had depression if they were not only using more than one AED but also using a
clonazepam drug (88).

2.2.4 Seizure Type
The prognosis for epilepsy may be related to the type of epilepsy syndrome (68,125) but,
it is difficult to determine if certain types of seizures are predictive of more severe
epilepsy. As such, there has been plenty of research comparing types of seizures as
predictors of depression. The majority of studies are in agreement that the laterality of
where seizures originated and thus epilepsy type is not associated with the risk of
depression (50,82,83,87,97,105,123). Nonetheless, there have been few studies with
opposing results in samples spanning all ages. A systematic review that included a total
of 1095 children and adolescents aged 4 to 19 years with epilepsy identified four crosssectional studies where focal epilepsy was associated with depression to a higher degree
than generalized epilepsy (123). Symptomatic focal epilepsies, specifically, have been
found to be independently positively associated with depression, as measured by the Beck
Depression Inventory (93). This study included patients aged 1 to 60 years with a mean
age of epilepsy onset of 13.9 (SD= 9.5) years who had no history of status epilepticus for
6 months prior to study entry. Another study (n=90) had slightly differing results,
concluding that both generalized and focal epilepsy types are risk factors for depression
as compared to undetermined epileptic seizures (126). Their results may have limited
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external validity given they had a much larger proportion of undetermined seizure types
than is found in the general population. Conversely, one study found that children (n=48)
with generalized seizures self-reported more depressive symptoms, as measured by the
CDI, but this finding did not hold for the parent reports of their child’s depression (127).
Among hospitalized and/or ambulatory care patients (n=117 females and 85
males) between the ages of 18 to 50 years with epilepsy, depression was more common in
those with complex partial seizures and less common in those with secondary generalized
tonic-clonic seizures (124). Tonic-clonic seizures, specifically, have been found to be
associated with the anhedonia subscale of the CDI among children (96). Complex partial
seizures were also found be a positive clinical risk factor for depression (OR=0.112, p
=0.002) in patients aged 15 to 71 years (128). The number of seizure types was the
strongest predictor of depression in their study (OR= 3.77, p =0.049). A notable study
limitation is that their patients were from a tertiary epilepsy center, which may have led
to an overrepresentation of severe cases. There was further support for partial seizures as
a risk factor with another study finding that patients with partial seizures more frequently
reported having depressive systems, identified by the Hamilton Depression Rating Scale,
compared to patients with generalized epilepsy in their sample (n=116) with an age range
spanning 16 to 70 years (88).

2.2.5 Duration of Epilepsy and Age of Onset
Early severity of epilepsy in some cases may predict the overall duration of disease and
whether the child will ever outgrow it (129). Likewise, age of seizure-onset is associated
with the type of epilepsy syndrome that may, in turn, be associated with disease
prognosis (130,131). Although disease duration and age of epilepsy onset are not direct
predictors of the early severity of epilepsy, they are important clinical factors to explore
as risk factors for depression. The majority of studies are in agreement that age of
epilepsy onset is not related to depression (50,83,86,88,91,122–124,128) but the findings
on the relationship between duration of epilepsy and depression are inconclusive
(91,104,122–124,128). A comprehensive review (122) identified only two studies that
found a significant relationship between both these epilepsy-related factors and
depression in youth (82,87). One found both age of epilepsy onset and disease duration to
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be specifically related to the interpersonal domain score of the CDI (87). In addition to
both being predictors of depression, a younger age of onset was also significantly
associated with feelings of stigma among a community-based sample of adults with
epilepsy (132). The median age of onset in this sample was 22 (range=86) years with
43% of the sample having an onset before the age of 19.
In addition to being a risk factor of depression, a longer duration of epilepsy is
associated with the prevalence of MDD and anxiety in children and adolescents
(82,83,91). Duration of disease is also associated with depression in adults with one study
finding that having epilepsy for more than a decade increased the chances of having
clinically significant depression symptoms (52 cases and 52 controls) (OR= 6.21, 95%
CI= 1.66 to 23.32), assessed using the HADS (98,102). When comparing adult
outpatients (n=116) who had mild to severe depression, those in the moderate depression
group, identified by the Hamilton Depression Rating Scale, had the longest disease
duration (88).

2.3

The Importance of Family Environment in Childhood
Epilepsy

Childhood chronic diseases not only negatively impact the person with the disease but
also their families (133). In the case of epilepsy, disease onset has been shown to bring up
parental feelings of the ‘loss of a perfect child’ and that their child may always be
different than other children (133,134). The progression of the illness further exacerbates
problems by increasing feelings of frustration, hopelessness, depression, anger, and guilt
among family members (135). Over the course of the illness, changes in family relations
may occur due to the disease prognosis, the attached social stigma and/or the increased
focus of parents on their child with the health condition leading to a decreased focus on
their other children (133). As such, siblings of children with chronic epilepsy have been
found to have higher rates of psychiatric disturbances as compared to those with newly
diagnosed siblings (136).
Childhood chronic illnesses increase the child’s dependency, required long-term
care, family restrictions, and places an overall burden on the family (137). Along with
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regular parental duties, parents have the additional responsibilities of managing their
child’s condition and any consequences that may arise as a result, including school
absences and lower grades. Thus, the family dynamics are forced to change to
accommodate the needs of the illness (138). Unfortunately, these modifications in family
processes triggered by the onset of the illness are sometimes associated with worse
medical outcomes in the child with the condition (138). This may be due to families
adapting poorly to the disease leading to a stressful family environment (139,140). In
fact, the continued treatment of epilepsy has been found to increase the risk of
maladaptive responses by both the child and his/her family (141). Consequently, families
of children with a chronic illness are at a higher risk of developing psychological
problems as compared to their counterparts (142).
It is imperative that families adjust well to their child’s chronic illness as it is
presumed to influence how the child adapts (143). Poor family adaptation is likely to
increase the risk of poor child adjustment and in turn, the child is likely to experience
emotional or behavioural problems (140,144). However, due to the unpredictable nature
of epilepsy and the fears associated with seizures, there is an increased risk of parents
becoming over-protective and emotionally over-involved with their child (87,145).
Resources such as extended family social support, financial efficacy, and family mastery
have all been found to aid in parental adaptation to their child’s illnesses or disability
(140,146).

2.4

The Impact of Severity of Epilepsy on the Family

The severity of childhood epilepsy, characterized by a number of illness features such as
frequency and severity of seizures, is likely to affect how the family reacts to the disease.
Although no study has examined the direct impact that the overall severity of epilepsy
has on aspects of the family environment, a number of studies have found clinical
features of epilepsy to be related to family factors. One study found that stress within
families was higher in those with children who experienced more frequent seizures
compared to those with infrequent seizures or no chronic illness (147). Siblings of
children with frequent seizures expressed more concerns about their sibling’s epilepsy as
compared to siblings of children with infrequent seizures (147). Frequency of seizures in
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children and adolescents has also been found to be associated with an increased risk of
parental anxiety (148). Additionally, mothers of children with frequent seizures have
been found to exhibit more over-controlling, anxious, and demanding attitudes (149).
Mothers whose children with epilepsy fail to gain full control of their seizures have a
higher risk of trait anxiety (149). A opposing study found no difference in the risk of
parental anxiety based on the level of seizure control or seizure type (150).
Comorbid problems such as cognitive deficits are common in people with
epilepsy, with those who have more severe epilepsy being at higher risk (151). Children
with epilepsy and no comorbid conditions tend to have less anxious mothers as compared
to those with mild, moderate, or severe disabilities (150). Mothers of children with
epilepsy who suffer from motor or ‘mental retardation’ have a higher problem-solving
deficit, i.e. lower ability to resolve problems, compared to mothers of children with no
epilepsy or comorbidities (149). Furthermore, a longer duration of epilepsy has been
found to be associated with problematic family functioning and authoritarian maternal
parenting behaviours signified by over-punishing and rigid parental attitude (149).
Longer disease durations may be indicative of resistant and/or more severe epilepsies as
many people with childhood epilepsy outgrow it (74).

2.5

Family Factors and Youth Depression

A family’s expectations and attitudes towards epilepsy are strong predictors of long-term
psychological adaptation in individuals with epilepsy (137). Evidence suggests that
family factors may have an even greater influence on child psychological adjustment to
epilepsy than clinical factors (152). A recent study found depression in adolescents with
epilepsy to be attributed to their negative attitudes regarding their condition and their
family situations, rather than directly being a result of seizure or syndrome type or seizure
intensity (153). A second study found family functioning to be the second most important
predictor of child adjustment after pharmacological factors with other epilepsy-related
characteristics being of lesser significance (154).
Although the importance of family environment in childhood epilepsy is well
known, its role as a predictor of psychopathology in children with epilepsy is now
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increasingly being recognized and incorporated into epilepsy research (155). The findings
of a few studies indicate that caregivers’ response to epilepsy and their relationship with
their child may be important in lowering the risk of depression in youth who have
epilepsy. Particularly, poor quality of the child-parent relationship and parental rejection
have been shown to be associated with a higher risk of psychopathology in the offspring
with epilepsy (155). Parents’ lack of confidence in managing their child’s condition and
parental over-control are also risk factors for psychopathology and depressive symptoms,
respectively (156,157). Furthermore, large discrepancies between a mother and father’s
ratings of negative coping behaviours by their child with epilepsy was related to
children’s depressive symptoms, measured using the CDI, and to poorer self-concept
(80). This finding indicates that when two parents have different perceptions of their
child’s coping, the child is at an increased risk of psychiatric illnesses. These differences
in perceptions may be attributed to a number of factors including child-parent interaction
patterns and different parenting styles within a set of parents (80).
It is plausible that depression among primary caregivers can increase the
likelihood of depression in their offspring. This may be attributed to a number of
phenomena including the hereditary nature of depression, depression in parents resulting
in negative parenting behaviours, or a shared stressful family environment resulting in
mental health problems in all family members (158). Among adults with epilepsy (mean
age of nearly 25 years), the most important risk factor for depression was their caregiver
having depression (94). Other familial factors such as the caregiver’s education level,
perception of burden and stigma, and level of family functioning were only correlated
with depression in PWE through the meditational effects of the caregiver’s depression.
Thus, it may be vital to diagnose and treat depression in parents early on to reduce its
effect on the caregiver’s ability to nurture their child with epilepsy.
Rodenburg et al. (2005) reviewed the literature on family factors as risk factors
for psychopathology in children with epilepsy and found the contextual factors of family
stress, family functioning, and family resources to be important predictors of child
psychopathology, mainly depression. With the increased stress that epilepsy places on the
family it is likely that the entire family would be affected, leading to them experiencing
difficulties with functioning and cohesion (159). To cope with the epilepsy-associated
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demands, adequate family resources are required as they are deemed essential for better
psychological adjustment in children with chronic conditions (160). As both family
functioning and resources may be more amendable to change compared to clinical
factors, targeting them with effective family-based interventions may reduce the risk of
psychiatric problems in youth with epilepsy (154,159).
Although studies indicate that family factors may be associated with youth
depression among those with epilepsy, the specific role of these factors and how they
interact with the clinical features of epilepsy is generally unknown. It is plausible that
family factors may play an intermediary role between clinical factors and mental health
outcomes. Findings from past studies suggest that family reactions, behaviours, and
circumstances may potentially mediate the physical manifestation of epilepsy and
behavioural and emotional outcomes of family members (133). One study found that the
effect of seizure severity on children’s depressed mood was ‘completely mediated’ by
parent’s level of perceived stigma (161). In another study, the effect of epilepsy on
depressed mood was rendered non-significant when controlling for family processes
including restricted activity days, perceived life-threatening illness, and poor general
health (157). These studies are limited by the fact that they did not test the significance of
the indirect effect (path from exposure to outcome through the mediator). Furthermore,
the potential mediating effects of family factors have not yet been examined, especially in
the case of depression, representing an important target for future research.
One review concluded that most illness-related variables were not associated with
psychological and adaptation problems in children with less severe epilepsy and those
with adequate seizure control (152). However, illness-related variables were important
risk factors for psychopathology in children with severe epilepsy and those with poor
control of their seizures. As such, the effect that epilepsy has on negative psychiatric
problems may be based on severity of epilepsy. In agreement with other researchers, the
authors determined that family variables, the influence of epilepsy on family life, and the
family’s ability to cope with stress are factors that are likely to mediate the relationship
between illness factors and psychopathology in children with epilepsy (152).
Building on previous work and suggestions for future studies by researchers in
this field, the current study examines family factors as mediators in the relationship
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between severity of epilepsy and depressive symptoms. Below is a review of research on
the three family factors selected for this study [family functioning, family resources
(family mastery and health and extended family social support), and parental depressive
symptoms] as potential mediators.

2.5.1 Family Functioning as a Mediator
Although epilepsy can result in psychosocial problems in the person with the disease, it
also affects their family members and consequently their overall family system. Thus, it
is not surprising that families with a child/adolescent who has epilepsy experience poorer
family functioning (general functioning, affective responsiveness, affective involvement,
behaviour control, problem solving, and communication) as compared to families of
children without epilepsy (162). Families of children with epilepsy as compared to those
with diabetes or no chronic illness also have poorer family cohesion and quality of
parent-child communications (163,164). Another study had consistent findings when
comparing children who have epilepsy with those who have another chronic disease such
as asthma and found children with epilepsy to be less satisfied with their family
functioning (165). However, when these same children became adolescents they were no
more dissatisfied with their family relationships compared to adolescents with other
chronic diseases (79). Level of maternal satisfaction with family functioning also did not
differ between families of children with epilepsy or those with asthma (140).
Although studies have found poorer family functioning in families with a child
with epilepsy, whether the effect of epilepsy on family functioning varies by disease
severity, has not been examined. Individual aspects of epilepsy that characterize higher
disease severity have been linked to poorer family functioning, however. First, longer
disease duration was found to be associated with poorer family functioning scores
particularly in the areas of problem solving, communication, affective involvement,
behaviour control, and general functioning among children and adolescents who had
epilepsy with a disease duration ranging from 2 to 144 months (149). Among children
with intractable epilepsy, frequency of seizures has been found to be inversely associated
with poorer family cohesion (154). Lastly, mothers of children who had epilepsy along
with comorbid behavioural problems reported poorer family functioning compared to
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those whose had epilepsy alone (140). Having comorbid chronic illnesses was found to
lower family functioning which, in turn, led to experiencing poor psychosocial
functioning among adolescents and young adults with epilepsy (166). In this study poor
psychosocial functioning was defined as having poor quality of life along with high
depressive symptomology and anxiety (166). Therefore, it is plausible that family
functioning may play a mediating role in the relationship between severity of epilepsy
and youth psychopathology.
A number of studies have reported a relationship between family functioning and
depression in PWE. Children who have epilepsy and clinically significant depressive
symptoms reported experiencing greater family conflict within the past year as compared
to those without depression (121). However, approximately two years later, family
conflict in this small group of children (n=28) improved, suggesting that a family’s
response to their child’s epilepsy is not static but evolves over time (167). Mothers of
children who had depression reported poorer family functioning compared to those whose
child with epilepsy did not have depression (140). Among youth with childhood-onset
epilepsy, dissatisfaction with family functioning has also been found to be associated
with depressive symptoms (80,168). Family functioning has also been found to be
associated with depressive symptoms in mothers of adolescents with epilepsy (94). In this
study, family functioning was indirectly associated with adolescent internalizing and
externalizing problems through parental depressive symptoms and the level of rejection a
child felt towards his/her parents (94). Family functioning has also been found to partially
mediate the relationship between parental depressive symptoms and child health related
quality of life (169). Likewise, family functioning has been found to mediate the
relationship between behavioural problems and emotional well-being and moderate the
relationship between cognitive decline and self-esteem in children with epilepsy
(170,171).

2.5.2 Family Resources as a Mediator
Families vary in the level of resources they have available to them to assist them in
coping with stressful situations such as the care of a child with a chronic disease. Family
resources have been found to be more problematic for families of children with epilepsy
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compared to those with other chronic illnesses (140). For the purposes of this study,
family resources do not refer to financial assets but rather the concepts of extended
family social support and family mastery and health. Having sufficient social support is
critical for families when adapting to a chronic illness and has been found to be
associated with depression, irrespective of the level of stress in adults with epilepsy (99).
Specifically, familial social support provided by extended family has been found to
reduce the risk of depression in mothers of adolescents with epilepsy (172).
Several studies have found deficits in various aspects of family resources to be
associated with poor psychiatric health. The findings of one study indicated that families
with fewer resources are more likely to have children with poor psychosocial adaptation
(140). They found scores in all four subscales (esteem and communication, mastery and
health, extended family social support, financial well-being) of the family inventory of
resources for management (FIRM) to be significantly lower for children with depression
or behaviour problems as compared to those without depression or behaviour problems
(140). Austin and colleagues (1992) replicated the initial study and found poor family
mastery and extended family social support to be associated with behaviour problems in
children with epilepsy in a subsequent study. Moreover, level of parent-reported adaptive
family resources were inversely associated with the depression/anxiety subscale of the
Child Behaviour Checklist-Youth Self Report in children with epilepsy but not
depression alone as measured by the CDI (86). Contrary to these findings, among
adolescents with epilepsy, adaptive family resources did not differ in those with or
without depression and or those with or without anxiety (103).
A recent study found that improvement in neuropsychological functioning from
seizure-onset to three years post-diagnosis was associated with reductions in symptoms
of depression in children with epilepsy with better family mastery being a protective
factor in this relationship (171). Consistent with this finding, two studies found the
negative effect of parental depressive symptoms on child health-related quality of life and
child emotional well-being, to be moderated by level of family resources (169,170).
Although it is possible that family resources may be a moderator of the relationship
between severity of epilepsy and patient psychopathology, it is also possible that it could
be a mediator. A recent study found family resilience, a measure of family mastery, to
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significantly mediate the relationship between severity of epilepsy and self-esteem in
youth aged 13 to 16 years old (n=153) (81). Youth with more severe epilepsy reported
poorer family resilience, and in turn, had lower self-esteem as compared to those with
moderate-low disease severity.
To determine the casual order of the relationship between family resources and
patient psychopathology, a study examined whether family resources are predictive of
internalizing problems over time (156). They assessed whether family mastery at the time
of seizure-onset is predictive of internalizing problems, i.e. depression and anxiety, two
years post-diagnosis (156). They found that at baseline and at the two year-follow up,
family mastery was negatively associated with total behaviour problems, internalizing,
and externalizing problems. Baseline family mastery was significantly negatively
associated with increases in total, internalizing, and externalizing behaviour problems
from baseline to two years. Thus, family mastery predicted behaviour problems over time
with those who had higher baseline levels of family mastery showing improvement in
child behaviour problems (156).

2.5.3 Parental Depression as a Mediator
Diagnosis of a chronic illness has been found to be associated with depression among
caregivers (173). This may be attributed to the increased burden placed on caregivers and
the hours they spend caring for their dependent with the burden only increasing the
longer the time since diagnosis (173,174). Parental depressive symptoms are problematic
for growing children as they are likely to reduce the quality of the parent-child
relationship. Maternal depressive symptoms have been found to be positively associated
with uncertainty regarding their child’s epilepsy and boundary ambiguity (child’s role in
the family) and so may reduce the quality of care the child receives (175).
A systematic review found that mothers of children with epilepsy have high rates
of depression with prevalence of depression ranging from 12% to 49% across six studies
(176). A large portion (31.5%) of mothers of children with epilepsy seem to have a MDD
(177). The prevalence of depression and anxiety in mothers of children and adolescents
with epilepsy has been found to be significantly higher than that of mothers of healthy
children without epilepsy (86,149). Findings are mixed, however, as other studies found
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no difference in the risk of depression between mothers of children with epilepsy and
mothers of children without epilepsy or another chronic disease (178,179).
Clinical factors indicative of more severe epilepsies have been examined as risk
factors of parental depression. The presence of ‘mental retardation’ in children with
epilepsy, which is likely reflecting more severe epilepsy, was found to be associated with
lower maternal educational attainment and an increased risk of maternal depressive
symptoms (180,181). However, children having a learning disability and their fathers’
level of education were not associated with the risk of paternal depression (182). A longer
duration of epilepsy was also not associated with depression in either mothers or fathers
(181,182). Severity of epilepsy in children was found to be associated with paternal
depression one year post-diagnosis, however, the sample was too small for the findings to
be considered conclusive (n=11) (183). In this sample, fathers of children with
generalized seizures appeared to have more depressive symptoms 24 months postdiagnosis as compared to those with partial seizures (183).
There are mixed findings on whether past or current parental depression is
associated with depression in youth with epilepsy. A review by Otero (2009) concluded
parent’s psychopathology to be one of the most important family factors influencing child
psychological problems. In children with epilepsy, a family history of psychopathology
has been shown to be a risk factor for depression (184). In a hospital outpatient sample of
adolescents with epilepsy, parental psychopathology was found to be associated with
depressive disorders in youth (103). Parental depression was also found to be associated
with internalizing and externalizing behaviour problems in children and adolescents
(155). However, two other studies did not find maternal depression to be correlated with
children’s and adolescent’s risk of depression (86,178). In samples of people with more
severe epilepsy, the results of all studies are consistent finding parental psychiatric
illnesses to be predictive of psychiatric illnesses in their offspring. Among children with
chronic or difficult to control epilepsy, a past history of maternal psychiatric treatment
was found to be correlated with an increased risk of patient emotional and behavioural
disturbances (141). In a previous study, Hoare (1984) also found past psychiatric illnesses
in mothers, but not in fathers, to increase the risk of psychiatric illnesses in children with
chronic epilepsy.
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A number of studies have found parental depression to be associated with both the
severity of epilepsy and youth psychiatric illness. Thus, it is plausible that parental
depressive disorders may mediate the effect of severity of epilepsy on the risk of youth
depressive disorders. One study found parental anxiety/depression to be significantly
more common in parents of children who had more seizures and/or behaviour problems
(185). More depressive symptoms in mothers of children with epilepsy were found to not
only be associated with greater severity of illness and more child behaviour problems but
also with maternal perceptions of greater stigma, dissatisfaction with family relationships,
less extended family social support, and lower family income (172). Lastly, among
children and adolescents with intractable epilepsy, behaviour problems and attention
problems were found to be correlated with maternal depression but family income was
not (186).

2.6

Limitations of Previous Studies

With depression being a common negative outcome in PWE, many studies have assessed
its risk factors. However, it is also essential to establish how risk factors work together to
create pathways in which depressive disorders may arise. This in turn will help establish
targets for interventions to reduce the effect of less amendable clinical factors on the risk
of depression. For example, family factors are related to psychiatric disorders in epilepsy
patients and may be potential targets for supports but have yet to be explored as
intermediary variables between clinical factors and depression.
The casual relationships between risk factors and depression have not been
explored since nearly all previous studies have been cross-sectional, measuring the
exposure and outcome at the same time. Shortage of prospective studies has also made it
difficult to incorporate clinical factors near onset as predictors of subsequent depression.
Furthermore, the majority of studies have focused on assessing the individual effects of
each clinical factor, as opposed to exploring their combined effect that forms overall
severity of epilepsy, in turn, causing psychiatric illnesses. As no single clinical factor has
been established to be a predictor of psychopathology in PWE, it is likely that the effect
that epilepsy has on causing negative psychosocial outcomes is based on overall disease
severity. Lack of examination of disease severity as a risk factor for mental illnesses may
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have been attributed to the absence of a validated measurement tool to feasibly assess
severity of epilepsy; this has become available in the past decade (65).
Studies to date have employed a wide variety of samples, some of which are
highly unrepresentative of the general population of PWE. Many studies recruit their
participants from speciality care clinics and may have excluded milder cases of PWE.
However, individuals with well-controlled/less severe epilepsy may still experience
negative side effects such as the stigma that accompanies the disease and should be
included in study samples (187). The vast majority of studies that included adults did not
single out young adults, although the risk of depression in this age group may differ due
to different stressors in this life stage as compared to middle and older aged adults.
Furthermore, people who have been in remission for many years and thus have not had an
epilepsy-related medical visit are excluded in many study samples. It is important to
include this subgroup of people as having a chronic condition during their childhood is
likely to have an impact on their long-term psychosocial health. There may also be
common biological mechanisms related to epilepsy that places patients at a higher risk of
psychiatric illnesses as compared to people who have never had epilepsy.
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Chapter 3
3

Study Purpose, Objectives, and Conceptual Framework

This chapter will elaborate on the purpose of the study, state the objectives of this
research, and provide information regarding the conceptual framework used to guide this
project.

3.1

Study Purpose

The presence of childhood epilepsy may have long-term impacts on psychological wellbeing. Nonetheless, childhood clinical predictors of long-term outcomes such as
depression have rarely been examined. The focus of past cross-sectional and longitudinal
studies has been to assess the effect of each factor separately, with little attention to how
these factors may come together to predict subsequent severity of epilepsy which, in turn,
may lead to depression. The findings of these previous studies are inconclusive (reviewed
in Chapter 2) warranting further research, particularly regarding the association between
overall childhood severity of epilepsy and youth mental health disorders. Thus, this thesis
aims to determine whether severity of childhood epilepsy early in the disease course is
predictive of later depressive symptoms in youth.
Further, due to the multi-etiological nature of risk factors for depression and the
established importance of family factors in childhood epilepsy (reviewed in Chapter 2),
the role of family factors will also be investigated (133,159). Aspects of the family
environment will be examined as potential mediating factors in the casual relationship
between severity of epilepsy and depressive symptoms. To interpret these relationships,
the stress process model has been selected as the conceptual framework to guide this
research (refer to Section 3.3). Furthermore, as this is a long-term follow-up study, many
changes may have occurred with regards to the clinical state of epilepsy. The current state
of epilepsy is important to take into consideration as a number of cross-sectional studies
have found epilepsy-related clinical factors that occur concurrently with depression to be
associated with the risk of depression. Past severity of epilepsy may also be related to the
future clinical manifestation of the disease, and thus current clinical factors will also be
examined as mediators of the relationship between early severity of epilepsy and
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subsequent depressive symptoms.
An important step in epilepsy research is to elucidate pathways by which negative
mental health outcomes manifest, and to identify factors that are amendable to change
through interventions. The examination of family environment may present an
opportunity to counteract or minimize the risk of depression for youth by implementing
family-based interventions. Examining severity of epilepsy in the early course of the
disease will inform paediatric neurologists of its potential long-term implications for
patients. Lastly, the examination of proximal clinical factors will help determine if past
disease severity remains important or whether its effect is greatly reduced when
accounting for the current clinical situation.

3.2

Research Objectives

The following are the research objectives to be addressed in this thesis:
1. To assess the association between early severity of epilepsy during childhood and
subsequent depressive symptoms during adolescence and young adulthood,
approximately a decade after diagnosis.
2. To assess whether aspects of the family environment (family functioning, family
resources, parental depressive symptoms) play a mediating role in the relationship
between early severity of epilepsy and subsequent depressive symptoms in youth.
3. To assess whether clinical factors (five-year seizure freedom, current AED use) play a
mediating role in the relationship between early severity of epilepsy and subsequent
depressive symptoms in youth.

3.3

Conceptual Framework

The stress process model was adopted as a theoretical framework to guide this research as
presented in Figure 3.1 (188). According to the stress process model, stress occurs in two
ways: the occurrence of discrete events and relatively chronic ongoing problems with the
combination of both producing a synergistic effect on psychological well-being
(188,189). In the past, social scientists have examined the impact of life events, ongoing
life strains, coping behaviours, and social support networks and their influences on health
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independently, although these processes all work together and should be examined as
such (188). A key contribution of the stress process model is that it acknowledges the
interrelationship among factors that affect mental health outcomes (188,190). It is a
temporal framework where life stressors arise consecutively as the stress process unfolds
to depict the causal relationship between exposure and outcome (188,189).
The stress process model consists of primary stressors that, in turn, lead to
secondary stressors, stress mediators, and finally the stress outcome. Various studies
testing this framework have used depression as their outcome of interest (188,191–193).
Specifically, one study employed the stress process model to predict depressive
symptomology and major depression in adults with socio-demographic factors as the risk
factors, social support as the mediator and personal resources as the moderator (192). It
has also been used previously in epilepsy research for the health outcomes of cognitive
functioning, emotional wellbeing, and HRQoL among children and youth (169,170,194).
The diagnosis of epilepsy (primary stressor) and, in turn, living with epilepsy,
where its effect is based on disease severity (secondary stressor), can lead to depressive
symptoms (stress outcome). This relationship between severity of epilepsy and
depressive symptoms may be mediated by a number of family factors/processes. The
portion of the stress process model that this project aims to examine is how the secondary
stressor (severity of epilepsy) leads to the stress outcome (depressive symptoms) via
family mediators. The proposed stress mediators include family functioning, level of
family resources, and parental depressive symptoms. Within the stress process model,
mediators are coping or social support factors that produce variability in the outcome
(188–190). Lastly, in this model, it is important to control for the background factors that
describe the context of the stress through inclusion of the underlying characteristics of the
subjects. The confounders in this project include: (a) demographic characteristics, such as
child’s sex, family income, and parental living arrangements; and (b) clinical risk factors
of the exposure and outcome, such as behavioural problems, cognitive problems, seizure
type, and age at diagnosis.
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Background and Context of Stressors
Youth Sex
Age at Diagnosis
Seizure Type
Behavioural Problems
Cognitive Problems
Family Income
Parental Living Arrangements

Diagnosis of
Childhood
Epilepsy

Living with
Epilepsy
(Severity of
Epilepsy)

Youth
Depressive
Symptoms

Primary Stressor

Secondary Stressor

Stress Outcome

Family Functioning
Family Resources
Parental Depressive Symptoms
Five-Year Seizure Freedom
AED Use
Stress Mediators

Figure 3.1: Conceptual Framework based on the Stress Process Model
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Chapter 4
4

Methods

This chapter presents details of the data source used for this project, including the
sampling methodology, data collection, and the measurement tools. In Section 3.3, the
statistical methods used to analyze the data will be described. Finally, description of
analyses conducted to reduce the risk of bias will be discussed including the attrition
analysis and how missing data were handled.

4.1

Data Source

The data used for this study came from the Health-Related Quality of Life in Children
with Epilepsy Study (HERQULES) consisting of the initial two-year follow-up study and
the subsequent long-term follow-up study. HERQULES was a 10-year prospective study
that employed a two-stage clustered sampling strategy to recruit children with new-onset
epilepsy in Canada. In the first stage of sampling, all paediatric neurologists who were
members of the Canadian Association of Child Neurology or were added to the sampling
frame by a panel of experts were invited to participate in the study. A sample size of 72
members resulted, of whom 53 (74%) agreed to participate. Research ethics board
approval was obtained from the 17 relevant research ethic boards across Canada.
The second stage of sampling consisted of the paediatric neurologists recruiting
their eligible patients for the study based on the following inclusion criteria:
1. New case of epilepsy seen for the first time by a participating paediatric
neurologist within the data collection period;
2. Age at first diagnosis between 4 and 12 years;
3. Parent/caregiver must have been primarily responsible for the child’s care for at
least the past six months before completing questionnaires.
Patients were excluded if they met any of the following criteria:
1. Previously diagnosed with epilepsy by another physician;
2. Diagnosed with other progressive or degenerative neurological disorder;
3. Diagnosed with other major non-neurological disorder that may impact their
quality of life;
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4. Parent/caregiver had insufficient English language skills to complete
questionnaires.
The parents of eligible patients who agreed to provide their address were mailed a
letter describing the study and explaining that they would be asked to complete four
mailed questionnaires: baseline (post-diagnosis), six months, one year, and two years
post-diagnosis. These questionnaires sought information on their child’s HRQoL and
their family environment, and would track changes in a number of factors over time.
Parents were requested to provide informed consent for their child’s neurologist to
complete forms regarding their child’s severity of epilepsy, seizure type, treatment and
side effects at each follow-up. The parents’ self-administered questionnaires took
approximately 45 to 60 minutes to complete and were returned by mail, whereas the
physician forms took 5 to 7 minutes to complete and were faxed back to the HERQULES
office (Appendix A). Of the 455 eligible parents, 373 (82%) parents were successfully
recruited and 282 (76%) were retained at the 2-year follow-up. The Tailored Design
Method, which involves systematic follow-ups and reminders, was used throughout the
HERQULES project in an effort to achieve good response rates (195).
For the subsequent long-term follow-up study, a letter of information was sent to
invite parents and children over the age of 11 to participate to assess the current state of
health of these youth and young adults (approximately 8 and 10 years post-diagnosis).
Letters for the parents and their child explained that they would be required to complete
two self-administered questionnaires, similar to the parent questionnaires in the original
study, two years apart. The children had not previously completed questionnaires in the
original study but were now old enough to self-report their health status. There were 220
youth eligible to fill out the questionnaires available as either web-based or paper
questionnaires to increase participation rates (196). Research ethics approval was only
required from the Western University Health Science Research Ethics Board for the longterm follow-up, given the established relationship with families from the initial phase of
this project (Appendix D). Informed consent to contact and obtain information about the
PWE’s condition from their epilepsy care physician, if still receiving care, was obtained
from the parents if the PWE was under the age of 16, both the parent and PWE if between
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the ages of 16 and 18 and only the PWE if 18 years or older. Physicians, parents, and
youth all received a token of appreciation for participating.

4.2

Measurement

Below is a description of how the exposure, outcome, mediators, and confounders were
measured, categorized by respondent type (physician, parent, youth).

4.2.1 Physician Report
Severity of Epilepsy
The overall severity of epilepsy was measured using the Global Assessment of Severity
of Epilepsy (GASE) Scale (65). This single item tool is designed for neurologists to rate
their patient’s overall severity of epilepsy. The question asked is “Taking into account all
aspects of this patient’s epilepsy, how would you rate its severity at his/her last visit?
Please check one answer”. The options are as follows: (7) extremely severe, (6) very
severe, (5) quite severe, (4) moderately severe, (3) somewhat severe, (2) a little severe,
(1) not at all severe. The GASE has been found to have adequate construct validity,
stability and responsiveness to clinical changes as well as good intra and inter-rater
reliability (65,66).

Seizure Type
Physicians reported the epilepsy syndrome and types of seizures that the patient had
according to the ILAE’s classifications (primary generalized, absence, simple/complex
partial, BECRS, secondarily generalized, BECRS + secondarily generalized and
undetermined) (197,198). These two variables, seizure type and epilepsy syndrome, were
used to compute a summary variable grouping the seizures broadly into generalized,
partial or undetermined.

Behavioural Problems
Physicians reported whether patients had behavioural problems, rated the severity (mild,
moderate, severe) and reported on diagnosed behavioural problems.

37

Cognitive Problems
Physicians reported whether patients had cognitive problems, rated the severity (mild,
moderate, severe) and reported on diagnosed cognitive problems.

Age at Diagnosis
The age at the time of epilepsy diagnosis was determined based on the child’s date of
birth and the date of their first visit in which they were diagnosed by their paediatric
neurologist participating in the HERQULES study.

4.2.2 Youth Report
Depressive Symptoms
Youth depressive symptoms were measured using the Center for Epidemiological Studies
Depression Scale (CES-D)(199). The adult version was used as opposed to the child
version, as it was age appropriate for the majority of youth and would allow for a
consistent measure for the entire sample and across follow-ups (Appendix B). This is a
20-item scale that is designed to measure depressive symptoms in the general adult
population over the past week. Respondents are asked to rate on a four-point Likert scale
the number of days they felt a certain way ranging from 0 (rarely or none of the time/less
than one day) to 3 (most or all of the time/5-7 days). The total scores range from 0 to 60
with a score of 16 or higher indicating that the person may be at risk of having a
depressive disorder. The CES-D has been found to have high internal consistency,
concurrent validity and construct validity in the general population (199). The CES-D had
adequate internal consistency in our sample of youth with a Cronbach’s alpha of 0.69.

Seizure Freedom
At the 10-year follow-up, youth were asked “When was your last seizure? (It is OK to
provide your best guess)”. The options were: less than 6 months ago, 6 months ago to less
than 1 year ago, 1 year ago to less than 2 years ago, 2 years ago to less than 5 years ago, 5
years to less than 10 years ago, 10 years ago or more, I don’t remember. In the event that
youth did not report or did not recall how long ago their last seizure was, the value
reported by their primary caregiver was imputed. This variable was dichotomized into
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five years of seizure freedom being achieved or not achieved to handle the unequal size
between intervals and to be comparable with past studies.

AED Use
At the 10-year follow-up, youth were asked “Are you currently taking any medication(s)
to treat epilepsy or seizures?” and they responded with either “yes” or “no”.

4.2.3 Parent Report
Sex
The child’s sex was reported by their primary caregiver. They were asked “Is your child:”
and were provided with two options: “Male” or “Female”.

Family Income
Primary caregivers were asked “In which category is your total yearly household income
before taxes?”. At the 10-year follow-up, the income categories included: less than
$20,000, $20,000 to $29,999, $30,000 to $39,999, $40,000 to $49,999, $50,000 to
$59,999, $60,000 to $69,999, $70,000 to $79,999, $80,000 to $89,999, $90,000 to
$99,999, $100,000 to $149,999, greater than $150,000. These income categories were
collapsed into four categories of equal size: less than $50,000, $50,000 to $100,000,
$100,000 to $149,999, greater than $150,000 due to a low cell count in half the categories
and for ease of interpretation.

Parental Living Arrangements
Primary caregivers were asked “Are you currently living with a spouse or partner” with
the two options provide being “yes” or “no”.

Family Functioning
Family functioning was measured using the Family Adaptability, Partnership, Growth,
Affection and Resolve (APGAR)(200). This is a 5-item scale measuring perception of
family functioning by examining satisfaction with family relationships in the five
dimensions: Family Adaptability, Partnership, Growth, Affection and Resolve (Appendix
C). For each dimension, respondents are to rate the frequency of satisfaction with family
functioning on a three-point Likert scale ranging from 0 (hardly ever) to 2 (almost
always). The scores range from 0 to 10 with a higher score indicating more satisfaction
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with family functioning. In clinical and research settings, the Family APGAR has been
found to be both valid and reliable (200–202). The APGAR had high internal consistency
in our sample with a Cronbach’s alpha of 0.88.

Family Resources
The extent to which families had resources available to help them adapt to stressful life
events was measured using the Family Inventory of Resources for Management (FIRM)
(203) (Appendix C). The two subscales included were Family Mastery and Health (20
items) and Extended Family Social Support (4 items) as they have been found to be
associated with adaptation to childhood epilepsy (204). Respondents rate how each
statement describes their family situation on a four-point Likert scale ranging from 0 (not
at all) to 3 (very well). The FIRM has demonstrated adequate reliability and validity
(203). The FIRM had adequate internal consistency in our sample with a Cronbach’s
alpha of 0.91 for the family mastery and health subscale and 0.64 for the extended family
social support subscale.

Parental Depressive Symptoms
Parental depressive symptoms were measured using the same measure completed by the
participating youth, the Center for Epidemiological Studies Depression Scale (CES-D)
(199), described in Section 3.2.2 (Appendix C). The CES-D had adequate internal
consistency in our sample of parents with a Cronbach’s alpha of 0.74.

4.3

Statistical Analysis

All analyses were conducted using SAS software version 9.2 for Windows
(SAS Institute Inc., Cary, NC, USA). Below is a description of the analyses conducted:
descriptive, multiple linear regression, mediation and attrition analysis.

4.3.1 Descriptive Analysis
Clinical, familial, and demographic characteristics of the sample were described using
frequencies and proportions for categorical variables, and means and standard deviations
for continuous variables at each of the data collection points (baseline, 6 months, 1 year,
2 years, 8 years, 10 years). Bivariate regression analyses were conducted to assess which
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factors were associated with the outcome without controlling for other factors. The
following relationships were examined: the outcome (youth depressive symptoms) and
the exposure (severity of epilepsy), the outcome and the mediators (family functioning,
family resources, parental depressive symptoms, five-year seizure freedom, AED use),
and the outcome and potential confounders (sex, age at diagnosis, seizure type,
behavioural problems, cognitive problems, parental living arrangements, family income).

4.3.2 Multiple Linear Regression Analysis
A multiple linear regression analysis was conducted with youth depressive symptoms as
the outcome to examine its relationship with the exposure (severity of epilepsy) while
controlling for a number of clinical and demographic confounders. Potential confounders
were sex, age at diagnosis, seizure type, behavioural problems, cognitive problems,
parental living arrangements, and family income. The confounders were selected based
on those factors that have been found to be predictors of depression in PWE and are
likely to be associated with severity of epilepsy (41,78,82,87,88,93,97,123,126,132,205–
208).
The outcome of interest, youth depressive symptoms, was measured at the 10year follow-up. The exposure of interest, severity of epilepsy, was measured at the 2-year
follow-up to allow physicians sufficient time to characterize the seizure type and try to
arrive at whether an effective combination of drugs could be found to control seizures
(74,77). The clinical confounders (seizure type, age at diagnosis, behavioural problems,
cognitive problems) were measured at the 2-year follow-up, as they are highly associated
with the exposure of interest. The demographic confounders (parental living
arrangements, family income) were measured at the 10-year follow-up as they are likely
to be more predictive of the outcome, depressive symptoms at 10 years, as compared to
demographic characteristics around diagnosis. Additionally, these time points were
selected to reduce the risk of intermediate confounding that may introduce bias when
conducting the mediation analysis. Intermediate confounding may occur when the
exposure is a causal risk factor of a mediator-outcome confounder (209,210). Lastly, the
assumptions for linear regression (linearity, normality of residuals, lack of
multicollinearity, autocorrelation, heteroscedasticity) were all met.
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4.3.3 Mediation Analysis
Often in psychosocial research it is the case that a risk factor does not directly cause an
outcome but it arises through a third or intermediary variable. This third variable is
termed a ‘mediator’ and is a carrier of information along a casual chain (211). Figure 4.1
depicts the possible pathways between an exposure and outcome with and without the
presence of a mediator (212,213). The total effect (c=ab + c’) is the effect of the exposure
on the outcome without taking the mediator into account. The direct effect is the effect of
the exposure while controlling for the mediator (c’=c-ab) as if it were a confounder.
Lastly, the path from the exposure to the outcome through the mediator is termed the
indirect effect (ab) and is calculated from subtracting the total effect from the direct effect
(c-c’).

c
Exposure

Outcome

c’

Exposure

a

b
Mediator

Figure 4.1: Mediation pathway

Outcome
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In this thesis, both family (family functioning, family resources, parental
depressive symptoms) and clinical (five-year seizure freedom, AED use) factors were
assessed as mediators in the relationship of severity of epilepsy and depressive
symptoms. An important assumption of mediation is that the exposure is a predictor of
the mediator and that the mediator is a predictor of the outcome (214). Thus, the family
factors as potential mediators were measured at the 8-year follow-up to allow a temporal
order between exposure, mediators, and outcome, a practice that is optimal when
assessing casual relationships (215). Additionally, preliminary cross-lagged panel
analyses and regression analyses were conducted to determine the casual order between
severity of epilepsy and the selected family mediators (Appendix E). A cross-lagged
panel analysis is used to determine the direction of the relationship between two variables
measured at multiple time points in a longitudinal study. This is done by examining
whether variable X at Time 1 and variable Y at Time 2 are associated or variable Y at
Time 1 and variable X at Time 2 are associated (216). The results of these analyses found
that severity of epilepsy was predictive of each of the family mediators (family
functioning, family resources, parental depressive symptoms) and that these relationships
were likely not bidirectional. The clinical mediators were measured at the 10-year followup due to the nature of these variables as they are more likely to be predictive of
depressive symptoms and not vice versa. It is unlikely that depressive symptoms in the
past week could cause five years of seizure freedom being achieved and/or AEDs being
prescribed.
A rigorous method using generalized estimating equations (GEE) proposed by
Schlucter (2008) was used to test mediation, i.e. the significance of the indirect effect.
This method is based on the counterfactual framework where the influence of the
mediator on the exposure and outcome relationship is assessed by observing the same
individual at the same point in time with the mediator present or it absent. Thus, to apply
this method, the data set must be duplicated as depicted in Table 4.1.
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Table 4.1: Duplicated data set in preparation for GEE mediation analysis
ID

Y

X

G

M*

1

y1

x1

1

0

1

y1

x1

0

m1

2

y2

x2

1

0

2

y2

x2

0

m2

n

yn

xn

1

0

n

yn

xn

0

mn

The first set where the indicator variable (G) is equal to 1, the mediator (M*) is not
present and thus is not adjusted for when examining the association between the exposure
(X) and outcome (Y). This set may be fit to the following model:
E(Y) = β0 + β1X1 + θ0 + θX
= (β0 + θ0) + (β1 + θ)X
In the second set, G=0 and thus the mediator is present and being controlled for in the
assessment of the relationship between X and Y. This set can be fit to the following
model:
E(Y)= β0 + β1X1 + γM
The overall dataset created includes two copies per individual differing on whether the
mediator is controlled for or not and is then fitted to:
E(Y)= β0 + β1X1 + θG + θGX +γM*
This model computes the difference between the coefficients from the full model
(adjusted for the mediator) and the reduced model (unadjusted for the mediator), i.e. the
indirect effect (θ). This is done in SAS software using the PROC GENMOD function
which also computes the significance of the indirect effect using a robust “sandwich”
estimator for the computation of the standard error. The validity of the GEE approach for
different combinations of binary and continuous outcomes and mediators has been
verified in a simulation study (217).
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4.3.4 Attrition Analysis
An attrition analysis was conducted to determine whether the group of participants
retained by the 10-year follow-up and those who did not participate in the 10-year followup differ in terms of any clinical, family, or demographic factors. The two groups of
participants were compared on baseline clinical (severity of epilepsy, seizure type,
cognitive problems, behavioural problems, age at diagnosis), demographic (sex, parental
living arrangements, family income), and family factors (parental depressive symptoms,
family resources, family functioning) using t-tests to compare means for continuous
variables and chi-square tests and/or fisher’s exact test to compare proportions for binary
variables.

4.3.5 Missing Data
For a small number of patients where severity of epilepsy, seizure type, presence of
cognitive problems or, presence of behaviour problems was missing due to physicians not
having an opportunity to evaluate at the two-year follow-up, previously reported values
for these variables were imputed where possible. For severity of epilepsy and seizure
type, members of the research team reviewed all available study data, including when the
youth’s most recent seizure was; when AEDS were discontinued; communication
between the study coordinator and the primary caregivers of children with epilepsy at the
two-year follow-up; the type and etiology of seizures; and the trends in past and
subsequent severity of epilepsy and seizure types. Imputations were not made where there
was uncertainty regarding the risk of the previously reported type of seizures and severity
of epilepsy changing. For cognitive and behaviour problems, all available study data
including past history, trends and taking into consideration future reports on cognitive or
behaviour problems was used. These future reports included both follow-ups with their
physicians and parents reporting if their child ever had any cognitive (developmental
delay, learning disability) or behaviour problems (conduct disorder, oppositional defiant
disorder, attention deficit disorder and/or attention deficit hyperactivity disorder) at the
10-year follow-up. Imputations were not made where there was uncertainty regarding the
presence of these comorbidities at the two-year follow-up.
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Approximately 82% of the sample had no missing values for any of the variables
after imputations using previous follow-up data was implemented. Nevertheless,
conducting a full case analysis would result in loss of nearly 18% of the sample
potentially leading to the group of participants analyzed being unrepresentative of the
sample. The vast majority of missing values were attributed to the mediators and
demographic confounders as these variables were from the most proximal follow-ups.
The second imputation method selected to deal with the high proportion of missing
values was multiple imputation using the fully conditional method. Multiple imputation is
a superior technique to deal with missing data as it accounts for the uncertainty of
missing-data prediction (218). It consists of three phases. First, missing values are filled
in numerous times creating multiple data sets; 20 imputations were done in this project to
match the proportion of missing cases. These data sets are then analyzed separately and
lastly, the estimates are pooled taking into account the uncertainty due to having missing
data (218). The fully conditional method was used as it allows a different distribution for
each imputed variable; logistic regression was used for binary variables and the
predictive mean matching method was used for continuous variables (219). The
predictive mean matching method was selected over regression as it imputes random
values that are consistent with those observed in the dataset (219). All variables used in
the analyses models were used in the multiple imputation model (220). A sensitivity
analysis was run using list wise deletion for participants with any missing data to show
that the results of the imputed dataset were consistent with those from the complete-case
analysis (Appendix F).
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Chapter 5
5

Results

The study findings are presented in this chapter beginning with a description of the
sample and their families. Next, the results of the attrition and bivariate analyses are
presented (Sections 5.2-5.3). The last three sections (5.4-5.6) present the results of each
research objective.

5.1

Sample Characteristics

Characteristics of the youth that remained consistent over time (age at diagnosis, sex) and
youth self-report measures collected only at 10 years are shown in Table 5.1. Of the 131
youth who participated in the 10-year follow-up, 3 did not report on the outcome of
interest (depressive symptoms) and were excluded from the study. Of these youth, 37.2%
had depressive symptoms that were clinically significant (CES-D>16) with a group
average CES-D score of 12.6 (SD: 10.2). The youth in our sample ranged in age from 12
to 23 years with the average age being 17.8 (SD: 2.6) years at the 10-year follow-up.
These children were diagnosed with epilepsy between the ages of 3 and 12 years, with the
group average being 7.5 (SD: 2.5) years. There was a similar proportion of males (48.8%)
as there were females (51.2%). At the 10-year follow-up, the majority of youth were
living with family (84%) and only 8% were living with a roommate or partner. Almost all
the adolescents, except for 2%, were still in school. Of the young adults, 16% were not in
school at the 10-year follow-up due to taking a year off, already having completed their
post-secondary education, or not planning to continue their educational journey past high
school.
Over half (59.7%) the youth had been free of seizures for at least the past five
years and very few (11.6%) had experienced a seizure within the past year. Similarly, the
majority of the sample were not currently using AEDs (72.1%), with most having
discontinued use two or more years ago (65.8%). A small proportion of the youth had
never required AEDs to control their seizures (11.8%). The majority of youth were no
longer receiving care for their epilepsy (65%) and of those still receiving care, 4% were
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receiving epilepsy care from a family doctor, 13% from an adult neurologist, and 8%
from a paediatric neurologist.
Characteristics of the families of youth with epilepsy measured at all six data
collection points are shown in Table 5.2. The annual family income increased for 53% of
families, remained similar for 34%, and decreased for 14% from baseline to the 10-year
follow-up. At the 10-year follow-up, nearly half the sample had an annual household
income of $100,000 or greater, and very few had an annual household income of less than
$40,000 (11.7%). Nearly all of the primary caregivers who participated were the
children’s biological mothers. At the 10-year follow-up, majority of primary caregivers
were working either full or part-time (71%), 9% were not working, 12% were
homemakers, and 1% were students. Most primary caregivers had completed some form
of post-secondary education (81%), 10% had completed high school and 1% did not.
Also at the 10-year follow-up, the majority of primary caregivers were living with a
partner (79.1%) with 76% currently married (with 3% of those re-married), 13%
divorced, separated or widowed, and 3% never married. Overall, families were
functioning well and had an adequate amount of resources and this remained stable over
the 10-year period following the child’s diagnosis of epilepsy. The average score on the
CES-D among primary caregivers was highest at the time of diagnosis, but on average
remained stable over time. The prevalence of primary caregivers who had clinically
significant depressive symptoms did not fluctuate much over time, ranging from 23% to
28% across time points.
Characteristics of the youth at each of the six data collection points are shown in
Table 5.3. In our sample (n=129) the average severity of epilepsy improved from
somewhat severe at the time of diagnosis to a little severe by the six-month follow-up.
Following the six-month follow-up, on average, the severity of epilepsy remained stable.
From diagnosis to the 2-year follow-up, the severity of epilepsy for about a quarter of the
patients remained the same (28%), for approximately half it became less severe (57%),
and for 15% it became more severe. The types of seizures children were experiencing
were the same as those with which they were initially diagnosed at the 2-year follow-up
for almost all the patients (95%). At the 2-year follow-up, 35.7% of children had
generalized seizures and 51.2% had partial seizures. The number of children with
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cognitive problems nearly tripled from the time of diagnosis to the two-year follow-up,
while the increase in the number of children with behavioural problems was minimal. At
the 2-year follow-up, 19.4% of children had cognitive problems and 13.2% had
behavioural problems.

5.2

Attrition Analysis

A flow chart presenting the number of parents and youth retained at each data collection
point can be found in Figures 5.1 and 5.2. A sample of 373 parents of children with
newly diagnosed epilepsy were recruited to participate in the study. For the long-term
follow-up study at 8 and 10 years post-diagnosis, youth self-report was added. At the 10year follow-up, 131 (60%) youth self-reported on their health. The results of the attrition
analysis comparing youth who participated in the 10-year follow-up of the study with
those who did not are presented in Table 5.4. These two groups of youth did not differ in
terms of their sex, the age that they were diagnosed with epilepsy, the severity of their
epilepsy, or their seizure type. However, those who did not participate in the 10-year
follow-up were less likely to have been diagnosed with comorbid cognitive (27% vs. 7%)
or behavioural problems (18% vs. 9%) at the time of epilepsy diagnosis. Nonparticipators were also from families of lower income and fewer family resources, and
their primary caregivers were more likely to have depressive symptoms compared to
those who participated at the 10-year follow-up. There was no difference between
participants and non-participants for the level of family functioning and whether the
primary caregiver was living with their partner.
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Patients Identified (n= 496)

Excluded (n=41)

Eligible (n=455)

Declined (n=8)
Unable to contact (n=5)

QUESTIONNAIRES
RETURNED

QUESTIONNAIRES
SENT
Baseline (n= 442)

Lost to follow-up = 62
Parent withdraw = 7

Baseline (n=373)

6 months (n=373)

Lost to follow-up = 34
Became ineligible = 4
Parent withdraw = 1

6 months (n=334)

1 Year (n=334)

Lost to follow-up = 29
Became ineligible = 2
Parent withdraw = 2

1 Year (n=301)

2 Years (n=301)

Lost to follow-up = 17
Parent withdraw = 2

2 Years (n=282)

Excluded 66: 39 unable to
locate, 17 declined, 8
province withheld, 2 became
ineligible

8 Years (n=216)

Lost to follow-up = 23
PI withdraw = 1

8 Years (n=192)

10 Years (n=215)

Lost to follow-up = 30
Unable to contact = 8
Became Ineligible = 2
Parent withdraw = 2

10 Years (n=173)

Figure 5.1: HERQULES flow chart of parent sample
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Declined (n=36)
Unable to contact (n=8)

Eligible (n=220)

QUESTIONNAIRES
SENT

QUESTIONNAIRES
RETURNED

8 Years (n=176)

Lost to follow-up = 21
Youth withdrew = 1

8 Years (n=154)

10 Years (n=176)

Lost to follow-up = 40
Unable to contact = 7
Became eligible = 3
Youth withdrew = 1

10 Years (n=131)

Figure 5.2: HERQULES flow chart of youth sample

5.3

Bivariate Analysis

The results of the bivariate analysis (Table 5.5) suggest that early severity of epilepsy was
significantly associated with later depressive symptoms (β= 2.25, 95% CI: 0.63, 3.88). Of
the potential confounders, only age at diagnosis was significantly associated with
subsequent youth depressive symptoms (β= 0.95, 95% CI: 0.22, 1.68). Of the potential
mediators, family functioning (β= -0.60, 95% CI: -1.08, -0.11), family resources (β= 0.20, 95% CI: -0.36, -0.04), five-year seizure freedom (β= 7.65, 95% CI: 4.16, 11.14),
and AED use (β= -5.56, 95% CI: -9.55, -1.56) were all significant predictors of youth
depressive symptoms. The only potential mediator of the relationship between early
severity of epilepsy and subsequent youth depressive symptoms that was not significantly
associated with the outcome was parental depressive symptoms (β= 0.06, 95% CI: -0.13,
0.25).
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5.4

Objective 1

To determine whether early severity of epilepsy was an independent risk factor for
depressive symptoms among youth with epilepsy, a multiple linear regression analysis
was conducted adjusting for potential confounders. Severity of epilepsy was measured at
the 2-year follow-up and depressive symptoms were measured at the 10-year follow-up.
The following clinical and demographic factors were controlled for as potential
confounders: seizure type, cognitive problems, behavioural problems, age at diagnosis,
sex, family income, and parental living arrangements. The results (Table 5.6) suggest that
early severity of epilepsy was significantly associated with depressive symptoms,
adjusting for potential confounders, with a parameter estimate of 2.10 (95% CI: 0.42,
3.79 for a 1-unit increase on the GASE scale assessing severity of epilepsy. Thus, the
more severe the childhood epilepsy youth had, the more likely they were to have later
depressive symptoms.

5.5

Objective 2

5.5.1 Family Functioning
A generalized estimating equations (GEE) model was used to assess the potential
mediating effect of family functioning around eight years post-diagnosis on the
relationship between early severity of epilepsy and subsequent youth depressive
symptoms, adjusting for potential confounders. The potential confounders were the same
clinical (seizure type, cognitive problems, behavioural problems, age at diagnosis) and
demographic (sex, family income, parental living arrangements) factors that were
controlled for in the analysis to address the first objective. The GEE model computed
both the direct effect of severity of epilepsy on depressive symptoms, while adjusting for
family functioning (M*) and the indirect effect of this relationship (G*severity of
epilepsy) (Table 5.7). The total effect of severity of epilepsy assessed in the first
objective was 2.10 (95% CI: 0.42, 3.79). Once the potential mediating effects of family
functioning were adjusted for, the estimate of the direct effect decreased to 1.86 (95% CI:
0.10, 3.61). The magnitude of the indirect effect (i.e. the difference between the presence
of the potential mediator in the model or not) was 0.25, which indicates that family
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functioning reduced the effect that severity of epilepsy had on the risk of depressive
symptoms by nearly 12%. However, when testing the significance of the indirect effect,
the GEE model indicated that family functioning did not mediate the relationship
between early severity of epilepsy and subsequent youth depressive symptoms (ab= 0.25,
SE: 0.17, 95% CI: -0.08, 0.57).

5.5.2 Family Resources
The potential mediating effect of family resources around eight years post-diagnosis on
the relationship between early severity of epilepsy and subsequent youth depressive
symptoms, adjusting for potential confounders, was assessed (Table 5.8). The total effect
of severity of epilepsy assessed in the first objective was 2.10 (95% CI: 0.42, 3.79 and the
estimate of the direct effect when adding family resources (M*) into the model decreased
to 1.88 (95% CI: 0.13, 3.63). The magnitude of the indirect effect was 0.22, which
indicates that family resources reduced the effect that severity of epilepsy had on the risk
of depressive symptoms by 10%. However, when testing the significance of the indirect
effect, the GEE model indicated that family resources did not mediate the relationship
between early severity of epilepsy and subsequent youth depressive symptoms (ab= 0.22,
SE: 0.19, 95% CI: -0.15, 0.59).

5.5.3 Parental Depressive Symptoms
Parental depressive symptoms were not assessed as a potential mediator using a GEE
model as the results of the bivariate analysis revealed its lack of association with the
outcome of interest. Evidence suggests that a potential mediator must be associated with
the outcome to be eligible to mediate the relationship between an exposure and outcome
(221–223).

5.6

Objective 3

5.6.1 Five-Year Seizure Freedom
Similar to the second objective, a GEE model was used to assess the potential mediating
effect of 5-year seizure freedom by 10 years post-diagnosis on the relationship between
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early severity of epilepsy and subsequent youth depressive symptoms, adjusting for
potential confounders (Table 5.9). The potential confounders were the same as those in
the analyses to address the previous two objectives. The total effect of severity of
epilepsy assessed in the first objective was 2.10 (95% CI: 0.42, 3.79 and the estimate of
the direct effect when adding 5-year seizure freedom (M*) into the model decreased to 0.89 (95% CI: -1.15, 2.92). The magnitude of the indirect effect was 1.22, which
indicates that 5-year seizure freedom decreased the effect that severity of epilepsy had on
the risk of depressive symptoms by approximately 58%. When testing the significance of
the indirect effect, the GEE model indicated that 5-year seizure freedom mediated the
relationship between early severity of epilepsy and subsequent youth depressive
symptoms (ab= 1.22, SE: 0.44, 95% CI: 0.35, 2.09). Thus, the effect of early childhood
severity of epilepsy was found to be of lesser importance when taking into account the
more recent clinical presentation of the disease. Those who had not achieved 5-year
seizure freedom were at greater risk of having depressive symptoms as compared to those
who had achieved 5 years of seizure freedom by the 10-year follow-up.

5.6.2 Antiepileptic Drug Use
The potential mediating effect of AED use 10 years post-diagnosis on the relationship
between early severity of epilepsy and subsequent youth depressive symptoms was
assessed (Table 5.10). The total effect of severity of epilepsy assessed in the first
objective was 2.10 (95% CI: 0.42, 3.79 and the estimate of the direct effect when adding
AED use (M*) into the model decreased to 1.51 (95% CI: -0.51, 3.54). The magnitude of
the indirect effect was 0.59, which indicates that AED use decreased the effect that
severity of epilepsy had on the risk of depressive symptoms by 28%. However, when
testing the significance of the indirect effect, the GEE model indicated AED use to not
mediate the relationship between early severity of epilepsy and subsequent youth
depressive symptoms (ab= 0.59, SE: 0.44, 95% CI: -0.27, 1.45).
A final note is that without employing multiple imputation (Appendix F), the magnitude
and direction of effects from the complete case analysis were similar to the findings
presented here.
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Table 5.1: Youth characteristics collected at the ten-year follow-up
Youth Characteristics at 10 Years
Age

mean (SD)
range

17.8 (2.6)
12-23

Age at Diagnosis

mean (SD)
range

7.5 (2.4)
3-12

Sex
Male
Female
Last Seizure
<6 months ago
>6 months ago to <1 year ago
>1 year ago to <2 years ago
>2 years ago to <5 years ago
>5 years ago to <10 years ago
10 years ago or more
Does not recall
Current AED Use
Yes
No
Last AED Used
<6 months ago
>6 months ago to <1 year ago
>1 year ago to <2 years ago
>2 years ago
Has never taken medication for seizures
Does not recall

n (%)
63 (48.8)
66 (51.2)
n (%)
12 (9.3)
3 (2.3)
7 (5.4)
18 (14.0)
57 (44.2)
20 (15.5)
11 (8.5)
n (%)
33 (25.6)
93 (72.1)
n (%)
2 (2.2)
0 (0)
2 (2.2)
61 (65.6)
11 (11.8)
14 (15.1)

*For the ‘last seizure’ variable this table does not include imputed values from the parent-report for
children who reported ‘do not recall’.
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Table 5.2: Family characteristics at each of the six data collection points
Family
Characteristics

Baseline

6 Months

1 Year

2 Years

8 Years

10
Years

Income n(%)
<$20,000
$20,000-$39,999
$40,000-$59,999
$60,000-$79,999
$80,000-$99,999
>$100,000
Does not know
Parental Living
Arrangements n(%)
Yes
No
Family Functioning
n=

6 (4.7)
12 (9.3)
24 (18.6)
22 (17.1)
22 (17.1)
38 (29.5)
1 (0.8)

9 (7.0)
14 (10.9)
17 (13.2)
18 (14.0)
22 (17.1)
42 (32.6)
3 (2.3)

6 (6.7)
17 (13.2)
16 (12.4)
17 (13.2)
24 (18.6)
43 (33.3)
4 (3.1)

6 (4.7)
14 (10.9)
21 (16.3)
23 (17.8)
14 (10.9)
45 (34.9)
1 (0.8)

4 (3.1)
11 (8.6)
11 (8.6)
15 (11.6)
17 (13.2)
59 (45.7)
6 (4.7)

2 (1.6)
13 (10.1)
9 (7.0)
15 (11.6)
16 (12.4)
61 (47.3)
2 (1.6)

116 (89.9)
13 (10.1)
14.3 (3.9)
129

112 (86.8)
16 (12.4)
14.4 (3.7)
128

113 (87.6)
16 (12.4)
14.2 (4.0)
129

114 (88.4)
15 (11.6)
14.2 (3.8)
128

106 (82.2)
18 (14.0)
14.2 (3.7)
124

102 (79.1)
17 (13.2)
14.6 (4.0)
119

Family Resources
n=

52.8 (10.7)
129

52.4 (11.5)
127

52.2 (10.8)
128

50.9 (11.5)
128

51.2 (11.3)
124

51.7 (11.9)
119

Parental Depressive
Symptoms n(%)
CES-D score >16
CES-D score <16

12.3 (9.5)
36 (28.1)
92 (71.9)

10.0 (8.6)
29 (22.8)
98 (77.2)

11.3 (8.4)
35 (27.3)
93 (72.7)

11.5 (9.6)
33 (25.6)
96 (74.4)

11.2 (9.4)
34 (27.4)
90 (72.6)

10.0 (9.0)
27 (22.7)
92 (77.3)

*Mean and standard deviation provided, unless otherwise stated.
*Family Functioning (APGAR) scores range from 1 to 20.
*Family Resources (FIRM) scores range from 16 to 72.
*Parental Depressive Symptoms (CES-D) scores range from 0 to 40.
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Table 5.3: Youth characteristics at each of the six data collection points
Characteristics
Severity of Epilepsy
mean (SD)
n=
Seizure Type
Generalized
Partial
Undetermined
Cognitive Problems
Yes
No
Behavioural Problems
Yes
No

Baseline

6 Months

1 Year

2 Years

8 Years

10 Years

2.5 (1.1)
125

1.9 (1.1)
120

1.9 (1.1)
118

1.7 (1.1)
117

1.8 (1.1)
30

1.8 (1.2)
32

53 (41.1)
75 (58.1)
1 (0.8)

54 (41.9)
69 (53.5)
0 (0.0)

51(39.5)
68 (52.7)
0 (0.0)

46 (35.7)
66 (51.2)
0 (0.0)

18 (14.0)
9 (7.0)
3 (2.3)

20 (15.5)
11 (8.5)
1 (0.8)

9 (7.0)
120 (93.0)

10 (7.8)
113 (87.6)

21 (16.3)
96 (74.4)

25 (19.4)
92 (71.3)

9 (7.0)
20 (15.5)

10 (7.8)
22 (17.1)

12 (9.3)
116 (89.9)

18 (14.0)
104 (80.6)

15 (11.6) 17 (13.2)
103 (79.8) 101 (78.3)

8 (6.2)
22 (17.1)

8 (6.2)
24 (18.6)

*Frequency (%) reported, unless otherwise stated.
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Table 5.4: Sensitivity analysis comparing baseline characteristics of youth retained for the
ten-year follow-up and those who did not participate
Variable

Did Not
Participate
(n=242)

Completed
Follow-Up
(n=131)

132 (55%)
110 (45%)

63 (48%)
68 (52%)

7.27

7.53

Seizure Type
Generalized
Partial
Undetermined
Severity of Epilepsy (mean)

89 (37%)
145 (60%)
5 (2%)
2.68

54 (41%)
75 (57%)
2 (2%)
2.45

Behavioural Problems
Yes
No

44 (18%)
195 (81%)

12 (9%)
118 (90%)

Cognitive Problems
Yes
No

65 (27%)
173 (71%)

9 (7%)
122 (93%)

89 (37%)
93 (38%)
42 (17%)

32 (24%)
56 (43%)
38 (29%)

205 (85%)
37 (15%)

118 (90%)
13 (10%)

Family Functioning (mean)

13.68

14.32

0.12

Family Resources (mean)

48.68

52.62

0.001

Parental Depressive
Symptoms (mean)

15.35

12.33

0.007

Sex

p-value

0.23
Male
Female

Age at Diagnosis (mean)

Household Income
<$50,000
$50,000-$99,999
>$100,000
Parental Living Arrangements
Living with spouse/partner
Not living with spouse/partner

0.30

0.74

0.07

0.02

<0.0001

0.008

0.15

*Reported as frequencies, unless otherwise stated.
*The p-value is from a chi-square or fisher’s exact test for categorical variables and t-test for continuous
variables.
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Table 5.5: Bivariate analysis with exposure, potential clinical and demographic
confounders, and potential family and clinical mediators
Variable

Co-efficient (SE)

95% Confidence Interval

2.25 (0.82)**

0.63, 3.88

Sex
(ref=male)

0.84 (1.80)

-2.72, 4.40

Age at Diagnosis

0.95 (0.37)*

0.22, 1.68

Seizure Type
(ref=generalized)

1.67 (1.83)

-1.94, 5.29

Cognitive Problems
(ref=yes)

-1.86 (2.31)

-6.44, 2.71

Behavioural Problems
(ref=yes)

-2.64 (2.67)

-7.93, 2.65

Family Income
(ref =<50,000)

-0.90 (0.86)

-2.60, 0.80

Parental Living Arrangements
(ref=yes)

2.48 (2.56)

-2.60, 7.56

Family Functioning

-0.60 (0.24)*

-1.08, -0.11

Family Resources

-0.20 (0.08)*

-0.36, -0.04

0.06 (0.10)

-0.13, 0.25

Five-Year Seizure Freedom
(ref=yes)

7.65 (1.76)***

4.16, 11.14

AED use
(ref=yes)

-5.56 (2.02)**

-9.55, -1.56

Severity of Epilepsy

Parental Depressive Symptoms

*p<0.02, **p<0.01, ***p<0.0001
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Table 5.6: Multivariate regression analysis assessing the relationship between severity of
epilepsy and depressive symptoms controlling for potential demographic and clinical
confounders with multiple imputation (n=129)
Variable

Co-efficient (SE)

95% Confidence Interval

Intercept

2.61 (8.76)

-14.56, 19.78

Severity of Epilepsy

2.10 (0.86)*

0.42, 3.79

Sex

0.18 (1.82)

-3.38, 3.74

Age at Diagnosis

0.97 (0.38)*

0.23, 1.71

Seizure Type

2.25 (1.81)

-1.29, 5.79

Cognitive Problems

0.69 (2.43)

-4.07, 5.45

Behavioural Problems

-3.59 (2.80)

-9.07, 1.89

Family Income

0.08 (1.00)

-1.88, 2.04

Parental Living Arrangements

0.54 (2.82)

-4.99, 6.07

Note: The mean R2 across imputations was 12.5% (range: 12.1% to 13.0%).
*p<0.02
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Table 5.7: GEE model assessing family functioning as a mediator between the
relationship of severity of epilepsy and depressive symptoms controlling for potential
demographic and clinical confounders with multiple imputation (n=129)
Variable

Co-efficient (SE)

95% Confidence Interval

Intercept

10.74 (9.23)

-7.35, 28.82

Severity of Epilepsy

1.86 (0.90)*

0.10, 3.61

Sex

-0.79 (1.78)

-4.29, 2.70

0.98 (0.35)**

0.30, 1.67

Seizure Type

1.92 (1.67)

-1.34, 5.19

Cognitive Problems

0.74 (2.34)

-3.85, 5.32

Behavioural Problems

-3.22 (3.11)

-9.30, 2.87

Family Income

0.36 (0.98)

-1.56, 2.28

Parental Living Arrangements

-0.15 (2.76)

-5.56, 5.27

G

-8.13 (4.65)

-17.24, 0.98

M*

-0.46 (0.26)

-0.97, 0.04

G*Severity of Epilepsy

0.25 (0.17)

-0.08, 0.57

G*Sex

0.97 (0.56)

-0.13, 2.07

G*Age at Diagnosis

-0.01 (0.05)

-0.12, 0.09

G*Seizure Type

0.33 (0.33)

-0.32, 0.97

G*Cognitive Problems

-0.05 (0.40)

-0.82, 0.73

G*Behavioural Problems

-0.38 (0.50)

-1.35, 0.60

G*Family Income

-0.28 (0.21)

-0.68, 0.13

G*Parental Living Arrangements

0.69 (0.63)

-0.54, 1.91

Age at Diagnosis

*p<0.05, **p<0.01
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Table 5.8: GEE model assessing family resources as a mediator between the relationship
of severity of epilepsy and depressive symptoms controlling for potential demographic
and clinical confounders with multiple imputation (n=129)
Variable

Co-efficient (SE)

95% Confidence Interval

Intercept

10.00 (10.04)

-9.68, 29.67

Severity of Epilepsy

1.88 (0.89)*

0.13, 3.63

Sex

0.08 (1.73)

-3.31, 3.46

0.88 (0.36)**

0.18, 1.59

Seizure Type

2.03 (1.70)

-1.29, 5.36

Cognitive Problems

1.09 (2.38)

-3.57, 5.75

Behavioural Problems

-3.59 (3.02)

-9.52, 2.33

Family Income

0.46 (1.02)

-1.55, 2.46

Parental Living Arrangements

-0.44 (2.80)

-5.94, 5.06

G

-7.39 (5.53)

-18.23, 3.46

M*

-0.13 (0.09)

-0.31, 0.06

G*Severity of Epilepsy

0.22 (0.19)

-0.15, 0.59

G*Sex

0.10 (0.22)

-0.33, 0.54

G*Age at Diagnosis

0.09 (0.07)

-0.06, 0.23

G*Seizure Type

0.22 (0.28)

-0.34, 0.77

G*Cognitive Problems

-0.40 (0.48)

-1.33, 0.53

G*Behavioural Problems

0.00 (0.30)

-0.58, 0.58

G*Family Income

-0.37 (0.30)

-0.97, 0.22

G*Parental Living Arrangements

0.98 (0.82)

-0.62, 2.58

Age at Diagnosis

*p<0.05, **p<0.02

62
Table 5.9: GEE model assessing five-year seizure freedom as a mediator between the
relationship of severity of epilepsy and depressive symptoms controlling for potential
demographic and clinical confounders with multiple imputation (n=129)
Variable

Co-efficient (SE)

95% Confidence Interval

Intercept

-5.21 (7.99)

-20.87, 10.45

Severity of Epilepsy

0.89 (1.04)

-1.15, 2.92

Sex

0.45 (1.73)

-2.94, 3.83

0.90 (0.34)**

0.24, 1.56

Seizure Type

2.21 (1.68)

-1.07, 5.50

Cognitive Problems

-0.32 (2.47)

-5.16, 4.53

Behavioural Problems

-1.66 (3.04)

-7.62, 4.30

Family Income

0.17 (0.94)

-1.67, 2.01

Parental Living Arrangements

0.55 (2.50)

-4.35, 5.46

G

7.82 (3.46)*

1.03, 14.61

M*

5.91 (2.09)***

1.82, 10.01

G*Severity of Epilepsy

1.22 (0.44)**

0.35, 2.09

G*Sex

-0.27 (0.48)

-1.20, 0.67

G*Age at Diagnosis

0.07 (0.11)

-0.13, 0.28

G*Seizure Type

0.04 (0.46)

-0.86, 0.94

G*Cognitive Problems

1.01 (0.69)

-0.35, 2.36

G*Behavioural Problems

-1.93 (1.04)

-3.97, 0.10

G*Family Income

-0.09 (0.25)

-0.58, 0.41

G*Parental Living Arrangements

-0.01 (0.74)

-1.47, 1.45

Age at Diagnosis

*P>0.05, **p<0.01, ***p<0.005
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Table 5.10: GEE model assessing AED use as a mediator between the relationship of
severity of epilepsy and depressive symptoms controlling for potential demographic and
clinical confounders with multiple imputation (n=129)
Variable

Co-efficient (SE)

95% Confidence Interval

Intercept

10.14 (10.93)

-11.30, 31.57

Severity of Epilepsy

1.51 (1.03)

-0.51, 3.54

Sex

-0.01 (1.76)

-3.45, 3.44

Age at Diagnosis

0.87 (0.36)*

0.17, 1.57

Seizure Type

2.67 (1.63)

-0.53, 5.87

Cognitive Problems

0.02 (2.44)

-4.77, 4.81

Behavioural Problems

-2.76 (2.97)

-8.57, 3.06

Family Income

-0.08 (0.96)

-1.97, 1.82

Parental Living Arrangements

0.26 (2.74)

-5.11, 5.62

G

-7.53 (5.59)

-18.48, 3.43

M*

-3.33 (2.43)

-8.10, 1.44

G*Severity of Epilepsy

0.59 (0.44)

-0.27, 1.45

G*Sex

0.19 (0.29)

-0.38, 0.75

G*Age at Diagnosis

0.10 (0.09)

-0.08, 0.28

G*Seizure Type

-0.42 (0.38)

-1.18, 0.33

G*Cognitive Problems

0.67 (0.59)

-0.49, 1.83

G*Behavioural Problems

-0.84 (0.76)

-2.33, 0.66

G*Family Income

0.16 (0.18)

-0.20, 0.52

G*Parental Living Arrangements

0.28 (0.40)

-0.50, 1.07

*p<0.02
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Chapter 6
6

Discussion

This chapter begins with a summary and interpretation of the study results (Section 6.1).
Next, the strengths and limitations of our study will be presented (Sections 6.2-6.3)
followed by recommendations for future research and the implications of our study
(Sections 6.4-6.5).

6.1

Summary of Results

This thesis aimed to assess the association between early severity of epilepsy and
subsequent depressive symptoms in youth diagnosed with epilepsy during their
childhood. With the stress process model as the guiding conceptual framework, family
factors were examined as potential mediators of this relationship. Given the lengthy time
period between the exposure and outcome, current clinical characteristics were also
examined as potential mediators of the relationship between severity of epilepsy and
youth depressive symptoms. To our knowledge, our study is the first to assess the nature
of the relationship between early severity of epilepsy in childhood and depressive
symptoms during adolescence and young adulthood.

6.1.1 Relationship Between Severity of Epilepsy and Depressive Symptoms
The first objective of this thesis was to assess the association between severity of epilepsy
early in the course of the disease and subsequent depressive symptoms. Childhood
epilepsy was presumed to have a lasting impression on children’s psychiatric health
during their adolescent and young adulthood years due to its impact on their psychosocial
development. Indeed, this study found early severity of epilepsy to be significantly
associated with subsequent youth depressive symptoms. The more severe childhood
epilepsy youth had, the greater their risk was for depressive symptoms as adolescents and
young adults. This finding is of clinical importance for neurologists as they routinely
assess patients’ severity of epilepsy. In the early course of the disease, neurologists may
be able to predict which children are at higher risk of acquiring depression later in their
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life and as such may educate parents whose child has a history of severe epilepsy on how
to effectively monitor them for symptoms of depression. They may also recommend
parents to promote positive mental health, provide a nurturing social environment, and
may refer patients to mental health professionals on a case-by-case basis.
Although no other study has examined early disease severity in childhood
epilepsy as a risk factor for future psychiatric illnesses, cross-sectional studies have found
an association between severity of seizures or epilepsy and psychiatric disorders (78–81).
Austin et al. (1996) examined illness severity, a measure based on seizure type, frequency
of seizures, and the number of AEDS/presence of side effects, as a predictor of mother
and teacher reported internalizing problems, which include behaviours such as
withdrawal, depression, and somatic complaints. They found that youth in the highest
severity of epilepsy group had significantly more internalizing problems, as reported by
both mothers and teachers using the Child Behaviour Checklist, compared to youth in the
lowest severity group. Using the same sample of youth with epilepsy, Haber et al. (2003)
examined disease severity as a risk factor of both self concept, measured using the
Children’s Self-Concept Scale and depression, measured using the CDI. They had similar
findings, where severity of epilepsy was highly correlated with self-concept, and
marginally (yet not significantly) correlated with youth depression symptoms. Their
sample differed from ours in two ways: the mean age of diagnosis for their sample was
slightly younger (4.9 years vs. 7.5 years) and patients who were not receiving treatment
for a year prior to study entry were excluded which was not a requirement for our study
sample. As such, they excluded patients with less severe epilepsy not requiring treatment,
potentially decreasing the range of disease severity in their sample. Our studies also
differed in the follow-up times used for assessing severity of epilepsy and depressive
symptoms, as they assessed both concurrently four years after study entry; consequently,
it is unknown when the onset of depression occurred relative to epilepsy diagnosis. We
assessed severity of epilepsy 2 years after diagnosis and depressive symptoms 10 years
after diagnosis, allowing a temporal order between exposure and outcome. As severity of
epilepsy changes over time, it is likely to influence the risk of depressive symptoms
differently depending on when it is measured and when depressive symptoms are
measured. Similarly, Chew et al. (2017) found higher severity of epilepsy to be
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associated with poorer self-esteem using the same measure for severity. The final study
by Turky at el. (2008) examined severity of seizures as a risk factor for psychiatric
disorders; despite their small sample size (n=56), they had findings consistent with our
study. Their results showed that increased severity of seizures and epilepsy, measured
using the Liverpool Seizure Severity Scale, was associated with the risk of parentreported depression and emotional problems in youth ages 5 to 17 with epilepsy.
Near the time of seizure-onset, a highly predictive characteristic of severity of
epilepsy, frequency of seizures, has been found to be associated with depression in
adolescents (82,83). In the first study, children and adolescents ages 9 to 18 who had
daily seizures in the early stages of their epilepsy were found to be at a higher risk of
depression and anxiety as compared to those who only had one seizure or were seizure
free (83). This study had a very small sample of 35 patients with an onset of epilepsy
ranging from 1 to 15.5 years. Depression was assessed using the CDI and anxiety was
assessed using the State Trait Anxiety Inventory. The second study with a larger sample
(n=140) of adolescents ages 10 to 18 years found more frequent weekly or daily seizures
at onset were associated with the risk of depression but not anxiety, measured using the
HADS (82). A notable distinction between these two studies is that the average disease
duration of the first study was larger at 5.6 (SD:3.9) years as compared to the latter study
with an average disease duration of 3.6 (SD:2.2) years for children and 4.8 (SD:3.4) years
for adolescents. Accordingly, patients in the last study may not have had anxiety due to
their longer duration of disease providing them with a longer window of time to adapt.
No other studies were found that examined characteristics of early childhood severity of
epilepsy as risk factors for later depressive disorders, as such there are no studies with
opposing findings.

6.1.2 Family Factors as Mediators
The second objective examined the potential mediating effects of family functioning,
family resources, and parental depressive symptoms in the relationship between early
severity of epilepsy and subsequent youth depressive symptoms. The rationale behind
this objective was that in previous studies these family factors had been found to be
associated with both the exposure and outcome. Clinical aspects of epilepsy, including a
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longer disease duration and higher frequency of seizures, have been found to be
associated with poorer family functioning and consequently, poor family functioning has
been found to be associated with depression in children with epilepsy
(80,121,140,149,154,168). Level of family resources were previously found to be
associated with severity of epilepsy and the risk of depression and internalizing behavior
problems in children with epilepsy (81,86,140,156). Parental depressive symptoms have
been shown to be associated with both severity of epilepsy and youth behavioural
problems including depressive disorders (172,185). Furthermore, these family factors
were found to be mediators of other similar relationships. A study of children with
chronic illnesses, including epilepsy, found the relationship between having a chronic
childhood illness and symptoms of anxiety and depression to be mediated by changes in
both family dysfunction and maternal symptoms of depression over time (224). Among
children with epilepsy, family mastery, an aspect of family resources, was found to
mediate the relationship between severity of epilepsy and self-esteem (81). To the best of
our knowledge, this is the first study to examine family functioning, family resources,
and parental depressive symptoms as mediators of the relationship between severity of
epilepsy and depressive symptoms.
Contrary to expectation, the results of our study suggest that the relationship
between early childhood severity of epilepsy and subsequent youth depressive symptoms
was not mediated by family functioning, family resources, or parental depressive
symptoms. There are a number of factors one might consider as potentially explaining
these findings. First, the majority of the sample had very mild epilepsy and thus their
epilepsy may not have created as much disruption in the family environment as more
severe epilepsy might have. This is supported by a previous study where families with
children who had uncontrolled epilepsy were at a higher risk of having a poor quality of
life (150). The results of our study also showed that most families were functioning well
overall and had an adequate amount of resources. Hence, there was minimal variability in
the sample, with most of the children living in a thriving family environment. As such,
we may have been underpowered to detect a mediating effect for the family factors due to
this lack of variability. The attrition analysis also revealed that families with lower
household incomes, fewer resources, and parental depressive symptoms were less likely
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to participate in the 10-year follow-up of this study. It is possible that if we had more
disadvantaged families participate, the family factors would have presented as mediators.
Second, there is potential for age-effects as the role of family factors, the severity
of epilepsy, and depressive symptoms may differ between adolescents and young adults.
Young adults may have greater autonomy and be less likely to be influenced by their
family environment, relative to adolescents. Emerging adulthood (usually ages 18 to 25)
is a time where many individuals move out of their homes to either attend post-secondary
institutions, begin employment, or to live with their romantic partner whereas others
continue to reside with their parents but begin to make independent life decisions (225).
Differences in the prognosis of epilepsy based on age of diagnosis may exist as a longterm prospective study found children diagnosed between the ages of 5 and 9 to be at the
highest risk of having intractable epilepsy (226). Lastly, there may also be age-related
differences in the prevalence of depression (227). To explore the potential for age effects
in our study, a post-hoc analysis was conducted performing a stratified analysis
separating adolescents (ages 12 to 17 years) from young adults (ages 18 to 24 years). The
results of the relationship between early severity of epilepsy and youth depressive
symptoms was no longer significant for either of the age groups. Subsequently, given no
total effect between severity of epilepsy and depressive symptoms, the family factors
were not mediators of this relationship. This may have been attributed to the small sample
sizes as there were only 62 adolescents and 67 young adults. Alternatively, age effects
may truly not exist as the prevalence of young adults in Canada co-residing with their
parents is increasing over time (228). Youth with chronic illnesses are especially likely to
be dependent on their parents longer (229) and as such, are likely affected by their family
environment similar to their adolescent counterparts. This was the case in our study
where only 8% of our sample was not residing with a family member at the 10-year
follow-up.
Third, the effect of family factors may have differed depending on the sex of the
primary caregiver who reported them. Psychiatric illness among mothers, but not fathers,
has been found to increase the risk of psychiatric illnesses in children with epilepsy (136).
Moreover, sex differences exist in the prevalence of depression in adults, with women
more commonly presenting with depression (230,231). There may be dissimilarities in
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how women and men react to their child’s disease severity as mothers and fathers have
been found to have differing attitudes towards their child’s epilepsy (80). These
differences in parenting attitudes may be attributed to one parent being the primary
caregiver and having different experiences with the child by communicating with and
watching over the child more often than the other parent. It is difficult to assess whether
these sex-based differences exist when examining only primary caregivers due to the
small number of male primary caregivers in Canada. To achieve a homogenous sample of
primary caregivers and reduce the risk of sex-based differences, a post-hoc analysis was
done removing the five participants whose primary caregiver was their father. The results
of the analyses remained consistent for all objectives as those presented in this thesis.
This may be attributed to the negligible influence having fathers in the sample may have
had due to their small sample size. The small proportion of primary caregivers being
fathers is consistent with the gender of primary caregivers of children with health
problems in Canada where the majority are mothers (232). Additionally, although
discrepancies between mother’s and father’s ratings of family functioning and family
resources have been found (80) these discrepancies may be minimal when the fathers
included are the primary caregivers and have similar experiences to the primary
caregiving mothers.
Finally, it is possible that the potential family mediators act in a causal chain to
mediate the relationship between severity of epilepsy and depressive symptoms.
Following the social interactional and ecological theoretical framework, family factors
have been grouped into four clusters based on their degree of proximity to the child’s
everyday experience: proximal, distal, contextual, and global (family socio-economic
status) (233). Rodenburg et al. (2006) suggested that proximal family factors (the quality
of the parent-child relationship and parenting) are the strongest predictors of child
psychopathology and thus, mediate the effects of contextual (the quality of other family
relationships) and distal factors (parental characteristics). They found the effects of both
parental depression and family functioning on the risk of child internalizing problems to
be mediated by parental rejection. In our study, parental depressive symptoms would
qualify as a distal family factor and family functioning and family resources would be
contextual factors. Hence, it is plausible that parental depressive symptoms may affect
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family functioning or family resources, which in turn, may lead to youth depressive
symptoms. This has been shown in a study where the effect of family functioning on the
outcome of youth internalizing problems was mediated by parental depressive symptoms
(234). Still, these relationships are complex with another study finding that family
functioning mediated the relationship between parental depressive symptoms and child
emotional well-being and family resources mediated the effect of family functioning in a
multiple mediation pathway (170). Differences in how family factors interact may be
attributed to the youth’s age; cultural differences in parenting styles, as some cultures
exercise stricter parenting than others; or the severity of epilepsy with more severe
epilepsies having a greater impact on the family.
Given the increased recognition of the value that family-centered care (FCC) has
in improving both family and child outcomes, there is a need to further examine the role
of family environment in childhood epilepsy to identify suitable targets for interventions
(235). According to the Maternal and Child Health Bureau, the following activities
characterize FCC: acknowledging the family as the constant in a child’s life, building on
family strengths, supporting the child in participating, honoring diversity, recognizing the
importance of community-based services, promoting an individual and developmental
approach, encouraging family-to family/peer support, developing family-centered
policies and practices, and celebrating success. Family factors not explored in our study
that may also be targeted within the FCC framework include increasing parents’
confidence in managing their child’s epilepsy and teaching parents how to provide
emotional support for their child (236). Both these factors may be affected by the severity
of epilepsy and have been previously found to decrease child behaviour problems over
time qualifying them as potential mediators for future studies to examine (156).

6.1.3 Current Clinical Factors as Mediators
The third and final objective examined the potential mediating effects of five years of
seizure freedom and AED use, a decade post-diagnosis, for the relationship between early
severity of epilepsy and depressive symptoms. The rationale behind this objective was to
determine whether early severity of epilepsy is a risk factor for future depressive
symptoms or whether its effect is based on it being a predictor of future severity of
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epilepsy. Past studies have shown that early disease severity may be a predictor for
whether a child will ever reach remission (77,237). Children with controlled epilepsy in
the early stages are also the ones who successfully discontinue AED use (74–76).
The results of our study found that five-year seizure freedom mediates the
relationship between early severity of epilepsy and subsequent depressive symptoms,
reducing the effect of severity of epilepsy by 58%. This finding indicates that most of the
effect of early disease severity is through gaining five-year seizure freedom which in
turn, is associated with the risk of depressive symptoms. Those who have been free of
seizures for the past five years a decade post-diagnosis are at lower risk of having
depressive symptoms compared to those who have experienced a seizure in the past five
years. This may be due to the fact that youth who have been free of seizures for this long
are no longer emotionally or socially affected by their epilepsy and thus are not at as high
of a risk of depressive symptoms, as compared to youth with active epilepsy. This is
supported by other studies, as one found PWE who have been in remission for greater
than five years to have less subjective handicap on all aspects of their daily life including
physical, social, emotional, and occupational (114). The authors suggest that this finding
may be attributed to a situation whereby the increasing time of remission increases
patients’ confidence that their epilepsy is resolved for good. Similarly, in another study,
adults who experienced none or very few seizures in the past year reported lower illness
intrusiveness in domains including relationship and personal development, intimacy, and
instrumental life compared to those who had frequent seizures (113).
Although five-year seizure freedom has not been examined as a mediator, the
results of one study are consistent with our findings where not being free of seizures for
the past five years was associated with the risk of reporting internalizing problems
(mainly depression and anxiety) (111). This study had a larger sample size (n=277) with
children diagnosed up to 11 years of age, and as such they had a younger age range at
their 9-year follow-up (8 to 17 years). In their sample, 64% of youth were free of seizures
by the 9-year follow-up and 31% were using AEDs, these proportions are similar to our
sample where 65% of youth had 5-year seizure freedom and 26% were using AEDs at the
10-year follow-up. Discordantly, in the same cohort of children, five-years of seizure
freedom was not associated with children’s HRQoL, but psychiatric disorders were
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associated with HRQoL (110). One reason presented by the authors for this lack of
association was that they used a generic instrument to measure HRQoL that may not have
been sensitive to changes in epilepsy. A multi-step mediation pathway may also exist
where five-year seizure freedom predicts psychiatric disorders which in turn, predict
HRQoL. A population-based Canadian study of non-institutionalized PWE (N=713) over
the age of 15 (Mean: 45.4 years) with ‘active epilepsy’, defined as either using an AED
or experiencing a seizure within the past five years, found five-year seizure freedom to be
associated with decreased odds of depression (112). Another study had consistent
findings where significantly fewer adults with one-year seizure freedom (4%) had
depression compared to those with active epilepsy (17%) (115). Although this study was
cross-sectional, it had a large sample size (n=1069) and measured depression using a
diagnostic screening tool (HADS).
AED use was the second potential clinical mediator examined and the results
found that it was not a mediator of the relationship between early severity of epilepsy and
depressive symptoms. Although AED use was not a mediator, it did reduce the effect of
early severity of epilepsy rendering it a non-significant risk factor for subsequent
depressive symptoms. This may be due to the fact that there was a large but not full
overlap between the variables of AED use and five-year seizure freedom. The majority
but not all of the youth who were no longer using AEDs were the ones who have been
free of seizures for the past five years. A explanation for the non-significant mediating
effect is that AEDs have been shown to have psychotropic effects with some reducing
and others increasing symptoms of depression (238). Unfortunately, we were unable to
account for AED types due to lack of information on which AEDs youth were prescribed.
This information likely would not have been that valuable due to the small sample of
youth who were using AEDs and the availability of several AEDs in Canada, with some
youth using various combinations. There may have also been a difference in the risk of
depression for youth on polytherapy treatment compared to those only using one AED
but, due to the lack of information and the small sample size, this could not be explored.
The findings of this study indicate that reaching five-years of seizure freedom
after a few years of having active epilepsy should be of paramount importance for
clinicians. Whether there is a difference between those who are in remission with
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treatment and those who are in remission without treatment must be explored further due
to the small number of youth in remission with treatment in our sample. Findings from a
study of adults with childhood-onset epilepsy followed for over 30 years indicated that
those in 5-year seizure remission without treatment were influenced less by their epilepsy
as compared to both those not in remission and those in remission with treatment (239).
This is consistent with the Antiepileptic Drug Withdrawal Study that included patients
over the age of 15 who were free of seizures for the past two years randomized to either
slow or no discontinuation of AEDs (240). They found individuals in remission with
treatment had greater feelings of stigma, felt that epilepsy restricted their social activities,
and believed it affected their work and employment opportunities. These findings may be
attributed to the successful discontinuation of AEDs lowering stigma associated with
having active epilepsy.

6.2

Strengths

The longitudinal prospective nature of this study allowed temporality between the
exposure, mediators, and outcome; a practice ideal for mediation analysis. It was one of
the first long-term follow-up studies that allowed for the examination of the occurrence
of a psychiatric disorder nearly a decade after the diagnosis of epilepsy in children. This
study included only new-onset cases of epilepsy so was an incident sample with a sample
size comparable to that of other studies. Data were collected at multiple time points
making recall bias highly unlikely. It is also one of only a few long-term studies to
include family factors as reported by the most knowledgeable person in the household,
the primary caregiver. The potential family mediators and the outcome of interest, youth
depressive symptoms, were all measured using validated tools. The exposure of interest,
severity of epilepsy, was physician reported using a validated measurement tool making it
a standardized measure of disease severity for all participants. The cohort in this study
was representative of the general population of youth with epilepsy as the majority of
cases were not severe. Lastly, this study provided an opportunity to examine the clinical
presentation of the disease in the early stages and its relationship to the presence of
seizures in the future.
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6.3

Limitations

This study was limited by the fact that depression in the early stages of epilepsy was not
measured so causality between severity of epilepsy and depressive symptoms cannot be
inferred. Measures for depressive symptoms would not have been feasible to implement
given the young age of the sample at the time of diagnosis and the self-administered
format for questionnaire completion. According to the parents’ reports on their child’s
psychiatric disorder history, diagnosis of depression, if applicable, occurred after the
diagnosis of epilepsy for our entire sample. A screening tool was used to identify who
may be at risk for depression rather than a diagnostic tool hence we cannot make
inferences regarding who has a depressive disorder and who does not.
Within the stress process model, we have specified the direction of the
relationships between variables, it is however possible that the outcome may have
affected the mediators. If youth depressive symptoms were chronic and were present for
over two years, they may have affected family functioning, family resources, and parental
depressive symptoms. Youth depressive symptoms may have also influenced whether
youth achieved five-year seizure-freedom if they required AEDs to control their seizures
and their psychiatric health affected their compliance to their medication.
Although we had a range in severity of epilepsy, we did not have many youth who
had very severe epilepsy and no one in our sample required surgery to control their
seizures. This means we cannot claim our findings are generalizable to youth with
intractable epilepsy. The loss of families who had lower household incomes, fewer family
resources, and were more likely to have parental depressive symptoms, produced a loss in
the variability of family environment. With the loss of families who would be most at risk
for negative outcomes, we were less likely to find significant effects for family factors.
Accordingly, our findings may not be generalizable to low socio-economic status areas or
disadvantaged populations. Our sample size, although one of the largest for a long-term
follow-up study in childhood epilepsy, may have been underpowered to detect significant
results in some of our analyses.
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6.4

Recommendations for Future Research

Future studies are warranted to explore the complexity of the relationship between
epilepsy-related clinical factors, family environment, and youth depressive disorders
given the importance of family in childhood epilepsy. These studies may examine
different family factors, the roles of family factors in multiple mediator models and the
potential moderating effects of family factors. Following family environment as children
age, peer social support becomes important and may be a factor to examine as a potential
mediator between severity of epilepsy and mental health outcomes. In a previous study, it
was found to mediate the relationship between disease severity and family mastery (241).
Studies with larger samples may examine the effects of age by stratifying by adolescent
and adult ages given relatively different stressors between these age groups. Future
studies should repeat a similar study with different psychiatric disorders as they are very
common in youth with epilepsy such as anxiety or suicide. Future studies should also
repeat a similar study in a more severe population of youth with epilepsy or those in
disadvantaged areas.

6.5

Implications and Conclusions

The findings from this study suggest that early severity of epilepsy in childhood may be
associated with depressive symptoms years later during adolescence and young
adulthood. Health care professionals may consider educating parents on the high
prevalence of depression in youth with epilepsy and offer resources on how depressive
symptoms may present to aid parents in recognizing depression if it occurs. Physicians
may also consider routinely screening for depression during examinations. A screening
tool called the Neurological Disorders Depression Inventory for Epilepsy is a validated
epilepsy population specific tool that can rapidly detect depression in clinics and is not
resource intensive (37). Although our study did not find family factors to play mediating
roles in the relationship between severity of epilepsy and depressive symptoms, this does
not imply that they are not important. More research is required to uncover the roles of
various family factors, their interrelations, and the usefulness of FCC in families of
children with epilepsy. The finding that the influence of early severity of epilepsy is
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mediated by seizure freedom for the past five years a decade after diagnosis of epilepsy
indicates that children with severe childhood epilepsy are mostly at a high risk of
depressive symptoms if they do not eventually gain control of their seizures. Having
severe childhood epilepsy does not necessarily condemn children to have unfavourable
psychiatric health in their adult years given there are opportunities to improve disease
severity with surgery and other interventions if it does not resolve with AEDs.
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APPENDIX A: PHYSICIAN FORM
Patient’s Date of Birth (dd/mm/yy): __________

Site #:_____________

Please answer the following questions based on information from this patient’s most
recent visit and return upon completion

1.

Date of patient’s last visit (dd/mm/yy): _______________ or Date of Telephone F/U
(dd/mm/yy)____________

2.

Date form completed (dd/mm/yy): _________________

If information for 3 thru 7 is unchanged from baseline (diagnosis) visit, please check here
and proceed to 8.
3. Seizure type(s):

1) ______________________

2)________________________

3)______________________

4)________________________

4. Epilepsy syndrome: _________________________
5. Convulsive status epilepticus:
No
Yes
6. Exclusive nocturnal seizures:
No
Yes
7.

Age of first seizure (excluding febrile seizure): _______ yrs

8. Does this patient have any family with epilepsy?
No
Yes
9. Number of AEDs currently: ________
10. Number of AEDs total: ________
11. Is this patient of school age?
No
Yes → Grade: ___

regular class

regular class with resource

special class
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12. Does the patient have behavioural problems?
No (normal)
Yes → Please check one:

mild

moderate

severe

Diagnosis: _____________________
13. Does the patient have cognitive problems?
No (normal)
Yes → Please check one:

borderline

mild

moderate

severe

Diagnosis: ______________________
14. Does this patient have motor problems?
No
Yes → Please check one:

mild

moderate

severe

Diagnosis: ______________________
15. Other neurological deficits? Please specify: ______________________________________
______________________________________
16. Taking into account all aspects of this patient’s epilepsy, how would you rate its severity at
his/her last visit? Please check one answer.
Extremely severe
Very severe
Quite severe
Moderately severe
Somewhat severe
A little severe
Not at all severe
17. Rate the following aspects of this patient’s epilepsy at his/her last visit.
Check one box using the following 7-point scale:
1 = none or never
7 = extremely frequent, severe or high
1
Frequency of seizures
Intensity of seizures
Falls or injuries during seizures
Severity of post-ictal period
Amount of antiepileptic drugs
Side effects of antiepileptic drugs
Interference of epilepsy or drugs with daily activities

2

3

4

5

6

7
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APPENDIX B: YOUTH SELF-REPORT MEASUREMENT TOOLS
Center for Epidemiological Studies Depression Scale (CES-D)
Please read these sentences that say something about how people sometimes feel and circle the number of
the category on this page that best indicates how often you have felt this way in the past 7 days.

Rarely or
none of the
time (less than
1 day)
a) I was bothered by things that
usually don’t bother me.
b) I did not feel like eating; my
appetite was poor.
c) I felt that I could not shake
off the blues even with help
from my family or friends.
d) I felt that I was just as good
as other people.
e) I had trouble keeping my
mind on what I was doing.
f)

I felt depressed.

g) I felt that everything I did
was an effort.
h) I felt hopeful about the
future.
i) I thought my life had been a
failure.
j)

I felt fearful.

k) My sleep was restless.
l)

I was happy.

m) I talked less than usual.
n) I felt lonely.
o) People were unfriendly.
p) I enjoyed life.
q) I had crying spells.
r)

I felt sad.

s) I felt that people dislike me.
t)

I could not get “going”.

During the Past Week:
Occasionally
Some or a
or a moderate
little of the
amount of
time
time
(1-2 days)
(3-4 days)

Most or all of
the time
(5-7 days)
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APPENDIX C: PARENT REPORT MEASUREMENT TOOLS
Family Adaptability, Partnership, Growth, Affection Resolve (APGAR)
Now we would ask that you think about the following and check the answer that best describes how you
feel most of the time. Please be honest.

a)

When something is bothering me, I can ask my family for help.

Never

Hardly

Some of
the time

Almost
always

Always

b) I like the way my family talks things over and shares problems with me.

Never

c)

Hardly

Some of
the time

Almost
always

Always

Almost
always

Always

Some of
the time

Almost
always

Always

Some of
the time

Almost
always

Always

I like how my family lets me try new things I want to do.

Never

Hardly

Some of
the time

d) I like what my family does when I feel mad, happy, or loving.

Never

Hardly

e) I like how my family and I share time together.

Never

Hardly
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Family Inventory of Resources for Management (FIRM): Family Mastery and Health and Extended Family
Social Support Subscales
The next set of questions asks about what social, psychological, community and financial resources
families believe they have available to them in the management of family life. To complete this inventory
you are asked to read the list of “Family Statements” one at a time. In each statement, “family” means your
immediate family (mother and/or father and children.) Then ask yourself: “How well does the statement
describe our family situation?”
Then make your decision by circling one of the following:
0 = Not At All
1 = Minimally
2 = Moderately
3 = Very Well

This statement does not describe our family situation. This does not
happen in our family.
This statement describes our family situation only slightly. Our family
may be like this once in a while.
This statement describes our family situation fairly well. Our family is
like this some of the time.
This statement describes our family very accurately. Our family is like
this most of the time.

Minimally

Moderately

Very Well

Family Statements:
a. Being physically tired much of the time is a problem in our family
b. We have to nag each other to get things done
c. We do not plan too far ahead because many things turn out to be a matter
of good or bad luck anyway
d. Having only one person in the family earning money is (or would be) a
problem in our family
e. It seems that members of our family take each other for granted
f. Sometimes we feel we don’t have enough control over the direction our
lives are taking
g. Certain members of our family do all the giving, while others do all the
taking
h. We seem to put off making decisions
i. Our family is under a lot of emotional stress
j. Many things seem to interfere with family members being able to share
concerns
k. Most of the money decisions are made by only one person in our family
l. It seems that we have more illness (colds, flu, etc.) in our family than
other people do
m. In our family some members have many responsibilities while others
don’t have enough
n. It is upsetting to our family when things don’t work out as planned
o. Being sad or “down” is a problem in our family
p. It is hard to get family members to cooperate with each other
q. Many times we feel we have little influence over the things that happen
to us
r. We have the same problems over and over – we don’t seem to learn from
past mistakes
s. There are things at home we need to do that we don’t seem to get done

Not at all

Please read and record your decision for each of the statements below.

0
0
0

1
1
1

2
2
2

3
3
3

0

1

2

3

0
0

1
1

2
2

3
3

0

1

2

3

0
0
0

1
1
1

2
2
2

3
3
3

0
0

1
1

2
2

3
3

0

1

2

3

0
0
0
0

1
1
1
1

2
2
2
2

3
3
3
3

0

1

2

3

0

1

2

3

Minimally

Moderately

Very Well

Family Statements:
t. We seem to be so involved with work and/or school activities that we
don’t spend enough time together as a family
u. Our relatives seem to take from us, but give little in return
v. We try to keep in touch with our relatives as much as possible
w. Our relative(s) are willing to listen to your problems
x. Our relatives do and say things that make us feel appreciated

Not at all
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0

1

2

3

0
0
0
0

1
1
1
1

2
2
2
2

3
3
3
3
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Center for Epidemiological Studies Depression Scale (CES-D)
Now we’d like to ask some questions about you. Please read these sentences that say something about how
people sometimes feel and circle the number of the category on this page that best indicates how often you
have felt this way in the past 7 days.
0.
1.
2.
3.

Rarely or none of the time (less than one day)
Some or a little of the time (1-2 days)
Occasionally or a moderate amount of time (3-4 days)
Most or all of the time (5-7 days)

During the past seven days:
a)

I was bothered by things that usually don’t bother me.

0

1

2

3

b) I did not feel like eating; my appetite was poor.

0

1

2

3

c)

0

1

2

3

d) I felt that I was just as good as other people.

0

1

2

3

e)

I had trouble keeping my mind on what I was doing.

0

1

2

3

f)

I felt depressed.

0

1

2

3

g) I felt that everything I did was an effort.

0

1

2

3

h) I felt hopeful about the future.

0

1

2

3

i)

I thought my life had been a failure.

0

1

2

3

j)

I felt fearful.

0

1

2

3

k) My sleep was restless.

0

1

2

3

l)

0

1

2

3

m) I talked less than usual.

0

1

2

3

n) I felt lonely.

0

1

2

3

o) People were unfriendly.

0

1

2

3

p) I enjoyed life.

0

1

2

3

q) I had crying spells.

0

1

2

3

r)

I felt sad.

0

1

2

3

s)

I felt that people dislike me.

0

1

2

3

t)

I could not get “going”.

0

1

2

3

I felt that I could not shake off the blues even with help from my
family or friends.

I was happy.
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APPENDIX E: PRELIMINARY CROSS-LAGGED PANEL AND REGRESSION
ANALYSES
In this study, the two-year follow-up was used for the exposure of interest (severity of epilepsy) and the
eight-year follow-up was used for the potential family mediators. Thus, these time points were the main
focus when determining the casual order between severity of epilepsy and the potential family mediators
including family functioning, family resources and parental depressive symptoms. A cross-lagged panel
analysis was conducted for each potential mediator in both the study sample (N=129) and the entire
HERQULES project sample to compare results and whether associations changed when the sample size
was much larger. Additionally, multiple linear regression analyses were conducted to further clarify the
casual order between exposure and potential mediators.
Table E-1: Cross-lagged panel analysis examining the relationship between family functioning (APGAR
score) and severity of epilepsy (GASE score) for the study sample
Variable

Family
Functioning
Baseline

Family
Functioning
6 Months

Family
Functioning
1 Year

Family
Functioning
2 Years

Family
Functioning
8 Years

Family
Functioning
10 Years

Severity of
Epilepsy
10 Years

r=-0.31
p=0.08
N=32

r=-0.23
p=0.22
N=31

r=-0.30
p=0.10
N=32

r=-0.32
p=0.07
N=32

r=-0.30
p=0.11
N=29

r=-0.20
p=0.29
N=30

Severity of
Epilepsy
8 Years

r=0.13
p=0.49
N=30

r=0.26
p=0.18
N=29

r=-0.11
p=0.55
N=30

r=0.04
p=0.82
N=30

r=0.27
p=0.14
N=29

r=0.24
p=0.21
N=28

Severity of
Epilepsy
2 Years

r=-0.16
p=0.08
N=117

r=-0.09
p=0.32
N=116

r=-0.14
p=0.13
N=117

r=-0.17
p=0.08
N=116

r=-0.28
p=0.003
N=112

r=-0.21
p=0.03
N=108

Severity of
Epilepsy
1 Year

r=-0.20
p=0.03
N=118

r=-0.24
p=0.01
N=117

r=-0.21
p=0.02
N=118

r=-0.19
p=0.04
N=117

r=-0.21
p=0.03
N=113

r=-0.18
p=0.07
N=110

Severity of
Epilepsy
6 Months

r=0.03
p=0.72
N=120

r=-0.04
p=0.65
N=119

r=-0.03
p=0.77
N=120

r=0.01
p=0.96
N=119

r=0.05
p=0.57
N=115

r=0.06
p=0.55
N=110

Severity of
Epilepsy
Baseline

r=-0.12
p=0.17
N=125

r=-0.03
p=0.74
N=124

r=-0.07
p=0.41
N=125

r=-0.05
p=0.59
N=124

r=-0.07
p=0.42
N=120

r=0.01
p=0.91
N=115

The results (Table E-1) show that severity of epilepsy at two years is correlated with family functioning at
eight years (p<0.005) but family functioning at two years and severity of epilepsy at eight years are not
correlated with each other (p=0.82). Thus, early severity of epilepsy may be predictive of subsequent
family functioning and not vice versa. However, this finding may have been attributed to the small sample
size for severity of epilepsy at eight years. Thus, severity of epilepsy at two years and family functioning at
earlier time points (baseline, six months, one year) were also examined and none of these relationships
were significant further strengthening the hypothesis of the casual order of the relationship between
severity of epilepsy and family functioning.
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Table E-2: Cross-lagged panel analysis examining the relationship between family functioning (APGAR
score) and severity of epilepsy (GASE score) for all participants in the HERQULES study
Variable

Family
Functioning
Baseline

Family
Functioning
6 Months

Family
Functioning
1 Year

Family
Functioning
2 Years

Family
Functioning
8 Years

Family
Functioning
10 Years

Severity of
Epilepsy
10 Years

r=-0.17
p=0.26
N=45

r=-0.16
p=0.29
N=44

r=-0.22
p=0.14
N=45

r=-0.35
p=0.02
N=45

r=-0.32
p=0.04
N=40

r=-0.27
p=0.09
N=39

Severity of
Epilepsy
8 Years

r=-0.06
p=0.69
N=48

r=0.02
p=0.89
N=47

r=-0.16
p=0.29
N=48

r=-0.03
p=0.83
N=48

r=0.11
p=0.49
N=46

r=0.01
p=0.94
N=39

r=-0.11
p=0.07
N=254

r=-0.19
p=0.01
N=174

r=-0.21
p=0.007
N=156

r=-0.17
p=0.007
N=261

r=-0.13
p=0.10
N=178

r=-0.19
p=0.02
N=160

r=-0.09
p=0.14
N=261

r=0.07
p=0.35
N=180

r=0.03
p=0.72
N=161

r=-0.10
p=0.11
N=273

r=-0.04
p=0.63
N=186

Severity of
Epilepsy
2 Years

r=-0.09
p=0.11
N=314

r=-0.07
p=0.25
N=292

Severity of
Epilepsy
1 Year

r=-0.19
p=0.0007
N=329

r=-0.14
p=0.02
N=306

Severity of
Epilepsy
6 Months

r=-0.03
p=0.60
N=335

r=-0.05
p=0.38
N=306

Severity of
Epilepsy
Baseline

r=-0.10
p=0.07
N=362

r=-0.05
p=0.34
N=327

r=-0.06
p=0.30
N=272
r=-0.13
p=0.02
N=280
r=-0.08
p=0.20
N=281
r=-0.07
p=0.22
N=294

r=0.00
p=0.97
N=167

The results were consistent when examining the entire HERQULES sample (Table E-3) as those found in
the study sample (Table E-2).
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Table E-3: Regression analysis to examine the association between severity of epilepsy at two years and
family functioning at eight years controlling for baseline family functioning
Variable

Co-efficient (SD)

p-value

Intercept

7.90 (1.12)

<0.0001

2-Year Severity of Epilepsy

-0.52 (0.24)

0.03

Baseline Family Functioning

0.52 (0.07)

<0.0001

A multiple linear regression analysis was conducted to further examine whether severity of epilepsy was
associated with future family functioning when taking into account the baseline levels of family
functioning. The results (Table E-3) found that severity of epilepsy at the two-year follow-up was
associated with family functioning at the eight-year follow-up while controlling for family functioning at
the time of epilepsy diagnosis (p<0.05). Thus, providing further support along with the cross-lagged panel
analysis of the casual order of this relationship.
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Table E-4: Cross-lagged panel analysis examining the relationship between family resources (FIRM score)
and severity of epilepsy (GASE score) for the study sample
Variable

Family
Resources
Baseline

Family
Resources
6 Months

Family
Resources
1 Year

Family
Resources
2 Years

Family
Resources
8 Years

Family
Resources
10 Years

Severity of
Epilepsy
10 Years

r=-0.37
p=0.04
N=32

r=-0.32
p=0.08
N=31

r=-0.39
p=0.03
N=32

r=-0.25
p=0.17
N=32

r=-0.47
p=0.01
N=29

r=-0.43
p=0.02
N=30

Severity of
Epilepsy
8 Years

r=0.11
p=0.5512
N=30

r=0.18
p=0.36
N=29

r=0.01
p=0.97
N=30

r=0.29
p=0.12
N=30

r=0.01
p=0.97
N=29

r=0.29
p=0.13
N=28

Severity of
Epilepsy
2 Years

r=-0.13
p=0.16
N=117

r=-0.10
p=0.30
N=115

r=-0.25
p=0.006
N=116

r=-0.25
p=0.007
N=116

r=-0.30
p=0.001
N=112

r=-0.29
p=0.003
N=108

Severity of
Epilepsy
1 Year

r=-0.19
p=0.04
N=118

r=-0.27
p=0.004
N=116

r=-0.33
p=0.0003
N=117

r=-0.21
p=0.02
N=117

r=-0.20
p=0.03
N=113

r=-0.27
p=0.004
N=110

Severity of
Epilepsy
6 Months

r=-0.06
p=0.51
N=120

r=-0.12
p=0.18
N=118

r=-0.17
p=0.06
N=119

r=-0.04
p=0.70
N=119

r=-0.01
p=0.94
N=115

r=-0.08
p=0.40
N=110

Severity of
Epilepsy
Baseline

r=-0.09
p=0.33
N=125

r=-0.09
p=0.31
N=123

r=-0.13
p=0.15
N=124

r=-0.10
p=0.29
N=124

r=-0.09
p=0.30
N=120

r=-0.10
p=0.31
N=115

The results (Table E-4) show that severity of epilepsy at two years and family resources at eight years were
significantly correlated (p=0.001) but severity of epilepsy at eight years was not correlated with family
resources at two years (p=0.12). However, this finding may have been attributed to the small sample size
for severity of epilepsy at eight years. Thus, severity of epilepsy at two years and family resources at earlier
time points (baseline, six months, one year) were also examined. While baseline and six-month family
resources were not significantly correlated with two-year severity of epilepsy, one-year family resources
were significantly correlated with two-year severity of epilepsy (p<0.01). Since the correlation between
severity of epilepsy at two years and family resources at eight years was stronger, the conclusion was that
severity of epilepsy is more likely to precede family resources and thus family resources may be examined
as a mediator in this study.
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Table E-5: Cross-lagged panel analysis examining the relationship between family resources (FIRM score)
and severity of epilepsy (GASE score) for all participants in the HERQULES study
Variable

Family
Resources
Baseline

Family
Resources
6 Month

Family
Resources
1 Year

Family
Resources
2 Year

Family
Resources
8 Year

Family
Resources
10 Years

Severity of
Epilepsy
10 Years

r=-0.17
p=0.25
N=45

r=-0.13
p=0.42
N=44

r=-0.18
p=0.24
N=44

r=-0.18
p=0.23
N=45

r=-0.40
p=0.01
N=40

r=-0.40
p=0.01
N=39

Severity of
Epilepsy
8 Years

r=-0.05
p=0.71
N=48

r=-0.01
p=0.94
N=47

r=-0.06
p=0.67
N=48

r=0.20
p=0.18
N=48

r=0.06
p=0.70
N=46

r=0.16
p=0.34
N=39

Severity of
Epilepsy
2 Years

r=-0.08
p=0.18
N=310

r=-0.04
p=0.48
N=292

r=-0.11
p=0.08
N=266

r=-0.11
p=0.08
N=254

r=-0.22
p=0.004
N=174

r=-0.24
p=0.002
N=156

Severity of
Epilepsy
1 Year

r=-0.18
p=0.001
N=325

r=-0.18
p=0.001
N=305

r=-0.22
p=0.0002
N=275

r=-0.19
p=0.002
N=260

r=-0.14
p=0.06
N=177

r=-0.19
p=0.01
N=160

Severity of
Epilepsy
6 Months

r=-0.12
p=0.03
N=332

r=-0.08
p=0.16
N=306

r=-0.11
p=0.08
N=276

r=-0.10
p=0.12
N=261

r=0.04
p=0.61
N=179

r=0.03
p=0.67
N=161

Severity of
Epilepsy
Baseline

r=-0.08
p=0.15
N=358

r=-0.04
p=0.51
N=327

r=-0.03
p=0.63
N=289

r=-0.05
p=0.46
N=273

r=-0.04
p=0.63
N=185

r=0.01
p=0.86
N=167

The results examining the entire HERQULES sample (Table E-5) provided further support for severity of
epilepsy preceding family resources as severity of epilepsy at the two-year follow-up and family resources
at the one-year follow-up were no longer significantly correlated as they were in the study sample (p=0.08).
Similar to the findings in the study sample, two-year severity of epilepsy and eight-year family resources
were significantly correlated (p<0.005) but two-year family resources and eight-year severity of epilepsy
were not (p=0.18).
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Table E-6: Regression analysis to examine the association between severity of epilepsy at two years and
family resources at eight years controlling for baseline family resources
Variable

Co-efficient (SD)

p-value

Intercept

19.12 (4.00)

<0.0001

2-Year Severity of Epilepsy

-2.00 (0.66)

0.003

Baseline Family Resources

0.68 (0.07)

<0.0001

A multiple linear regression analysis was conducted to further examine whether severity of epilepsy was
associated with the future amount of family resources taking into account the baseline amount of family
resources. The results (Table E-6) found that severity of epilepsy at the two-year follow-up was associated
with family resources at the eight-year follow-up even while controlling for the amount of resources
families had at the time of epilepsy diagnosis (p<0.005). Thus, providing further support along with the
cross-lagged panel analysis of the casual order of this relationship.

106
Table E-7: Cross-lagged panel analysis examining the relationship between parental depressive symptoms
(CES-D score) and severity of epilepsy (GASE score) for the study sample
Variable

Parental
Depressive
Symptoms
Baseline

Parental
Depressive
Symptoms
6 Months

Severity of
Epilepsy
10 Years

r=0.24
p=0.19
N=32

r=0.12
p=0.53
N=31

Severity of
Epilepsy
8 Years

r=-0.11
p=0.57
N=30

Severity of
Epilepsy
2 Years

Parental
Depressive
Symptoms
1 Year

Parental
Depressive
Symptoms
2 Years

Parental
Depressive
Symptoms
8 Years

Parental
Depressive
Symptoms
10 Years

r=0.20
p=0.27
N=32

r=-0.03
p=0.89
N=32

r=0.11
p=0.57
N=29

r=0.25
p=0.18
N=30

r=0.01
p=0.97
N=29

r=0.03
p=0.86
N=30

r=-0.16
p=0.39
N=30

r=0.20
p=0.29
N=29

r=-0.26
p=0.17
N=28

r=0.14
p=0.13
N=116

r=0.23
p=0.01
N=115

r=0.24
p=0.009
N=116

r=0.26
p=0.004
N=117

r=0.25
p=0.009
N=112

r=0.22
p=0.02
N=108

Severity of
Epilepsy
1 Year

r=0.17
p=0.07
N=117

r=0.29
p=0.002
N=116

r=0.29
p=0.001
N=117

r=0.33
p=0.0002
N=118

r=0.13
p=0.18
N=113

r=0.11
p=0.24
N=110

Severity of
Epilepsy
6 Months

r=0.14
p=0.13
N=119

r=0.19
p=0.04
N=118

r=0.16
p=0.09
N=119

r=0.06
p=0.53
N=120

r=0.00
p=1.00
N=115

r=-0.04
p=0.67
N=110

Severity of
Epilepsy
Baseline

r=0.15
p=0.09
N=125

r=0.08
p=0.40
N=123

r=0.20
p=0.03
N=124

r=0.15
p=0.09
N=125

r=0.01
p=0.92
N=120

r=-0.01
p=0.91
N=115

Severity of epilepsy at two years and parental depressive symptoms at eight years were significantly
correlated (p<0.01) but severity of epilepsy at eight years and parental depressive symptoms at two years
were not correlated (p=0.4) (Table E-7). However, this finding may have been attributed to the small
sample size for severity of epilepsy at eight years. Thus, severity of epilepsy at two years and parental
depressive symptoms at earlier time points (baseline, six months, one year) were also examined. Although
baseline parental depressive symptoms were not significantly associated with two-year severity of epilepsy,
six-month (p<0.02) and one-year parental depressive symptoms (p<0.01) were significantly associated with
two-year severity of epilepsy. Thus, it is possible that this relationship may be bidirectional.
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Table E-8: Cross-lagged panel analysis examining the relationship between parental depressive symptoms
(CES-D score) and severity of epilepsy (GASE score) for all participants in the HERQULES study
Variable

Parental
Depressive
Symptoms
Baseline

Parental
Depressive
Symptoms
6 Months

Parental
Depressive
Symptoms
1 Year

Parental
Depressive
Symptoms
2 Years

Parental
Depressive
Symptoms
8 Years

Parental
Depressive
Symptoms
10 Years

Severity of
Epilepsy
10 Years

r=0.05
p=0.72
N=45

r=0.10
p=0.53
N=44

r=0.13
p=0.41
N=45

r=0.06
p=0.71
N=44

r=0.23
p=0.15
N=40

r=0.28
p=0.09
N=39

Severity of
Epilepsy
8 Years

r=0.05
p=0.74
N=48

r=0.28
p=0.06
N=47

r=0.30
p=0.04
N=48

r=-0.07
p=0.64
N=46

r=0.17
p=0.25
N=46

r=-0.03
p=0.86
N=39

Severity of
Epilepsy
2 Years

r=0.05
p=0.40
N=312

r=0.16
p=0.005
N=292

r=0.14
p=0.03
N=268

r=0.17
p=0.008
N=253

r=0.22
p=0.003
N=174

r=0.20
p=0.01
N=155

Severity of
Epilepsy
1 Year

r=0.12
p=0.03
N=327

r=0.16
p=0.004
N=305

r=0.22
p=0.0002
N=277

r=0.21
p=0.0005
N=260

r=0.05
p=0.48
N=178

r=0.07
p=0.41
N=159

Severity of
Epilepsy
6 Months

r=0.08
p=0.14
N=333

r=0.06
p=0.32
N=306

r=0.12
p=0.05
N=278

r=0.03
p=0.61
N=261

r=-0.05
p=0.53
N=180

r=-0.08
p=0.34
N=160

Severity of
Epilepsy
Baseline

r=0.08
p=0.12
N=361

r=-0.01
p=0.90
N=327

r=0.05
p=0.42
N=291

r=0.11
p=0.08
N=272

r=0.02
p=0.74
N=186

r=-0.05
p=0.55
N=166

The results examining the entire HERQULES sample were similar to those found in the study sample
(Table E-8). However, the relationship between eight-year parental depressive symptoms and two-year
severity of epilepsy was stronger than the relationship between six-month parental depressive symptoms
and two-year severity of epilepsy, whereas in the study sample they were similar. Additionally, even with
the larger sample the relationship between parental depressive symptoms at two years and severity of
epilepsy at eight years was still not significant (p=0.64). Thus, it is more likely that parental depressive
symptoms precede severity of epilepsy.
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Table E-9: Regression analysis to examine the association between severity of epilepsy at two years and
parental depressive symptoms at eight years controlling for baseline parental depressive symptoms
Variable

Co-efficient (SD)

p-value

Intercept

3.38 (1.55)

0.03

2-Year Severity of Epilepsy

1.59 (0.66)

0.02

Baseline Parental Depressive Symptoms

0.35 (0.07)

<0.0001

A multiple linear regression analysis was conducted to further examine whether severity of epilepsy was
associated with future parental depressive symptoms taking into account the baseline parental depressive
symptoms. The results (Table E-9) found that severity of epilepsy at the two-year follow-up was associated
with parental depressive symptoms at the eight-year follow-up even while controlling for parental
depressive symptoms at the time of epilepsy diagnosis (p<0.05). Thus, providing further support along with
the cross-lagged panel analysis of the casual order between this relationship.
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APPENDIX F: SENSITIVITY ANALYSIS
Table F-1: Multivariate regression assessing the relationship between severity of epilepsy and depressive
symptoms controlling for potential demographic and clinical confounders without multiple imputation
(n=111)
Variable

Co-efficient (SE)

95% Confidence Interval

Intercept

1.55 (8.98)

-16.25, 19.36

2.19 (0.86)**

0.48, 3.91

Sex

0.06 (1.88)

-3.67, 3.80

Age at Diagnosis

0.79 (0.40)*

0.00, 1.58

Seizure Type

3.08 (1.93)

-0.75, 6.92

Cognitive Problems

-0.07 (2.51)

-5.05, 4.91

Behavioural Problems

-2.49 (2.97)

-8.37, 3.40

Family Income

-0.29 (0.98)

-2.24, 1.65

Parental Living Arrangements

1.30 (2.81)

-4.28, 6.87

Severity of Epilepsy

Note: R2=13.8%
*p<0.05, **p<0.02
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Table F-2: GEE model assessing family functioning as a mediator between the relationship of severity of
epilepsy and depressive symptoms controlling for potential demographic and clinical confounders without
multiple imputation (n=109)
Variable

Co-efficient (SE)

95% Confidence Interval

Intercept

10.21 (9.45)

-8.31, 28.73

Severity of Epilepsy

1.85 (1.03)

0.17, 3.86

Sex

-1.11 (1.90)

-4.83, 2.61

Age at Diagnosis

0.80 (0.37)*

0.07, 1.53

Seizure Type

2.73 (1.77)

-0.73, 6.19

Cognitive Problems

0.02 (2.53)

-4.93, 4.97

Behavioural Problems

-1.95 (2.76)

-7.37, 3.47

Family Income

0.13 (0.97)

-1.76, 2.03

Parental Living Arrangements

0.57 (2.85)

-5.01, 6.15

G

-8.62 (4.98)

-18.38, 1.13

M*

-0.50 (0.28)

-1.04, 0.04

G*Severity of Epilepsy

0.30 (0.20)

-0.09, 0.69

G*Sex

1.09 (0.63)

-0.14, 2.33

G*Age at Diagnosis

-0.04 (0.06)

-0.16, 0.08

G*Seizure Type

0.42 (0.39)

-0.34, 1.19

G*Cognitive Problems

-0.06 (0.43)

-0.91, 0.78

G*Behavioural Problems

-0.49 (0.52)

-1.50, 0.52

G*Family Income

-0.36 (0.25)

-0.85, 0.12

G*Parental Living Arrangements

0.77 (0.66)

-0.53, 2.07

*p<0.05
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Table F-3: GEE model assessing family resources as a mediator between the relationship of severity of
epilepsy and depressive symptoms controlling for potential demographic and clinical confounders without
multiple imputation (n=109)
Variable

Co-efficient (SE)

95% Confidence Interval

Intercept

13.37 (9.83)

-5.09, 32.64

Severity of Epilepsy

1.78 (0.98)

-0.15, 3.70

Sex

-0.25 (1.81)

-3.80, 3.29

Age at Diagnosis

0.61 (0.37)

-0.12, 1.35

Seizure Type

2.90 (1.79)

-0.60, 6.40

Cognitive Problems

0.70 (2.64)

-4.47, 5.87

Behavioural Problems

-2.51 (2.73)

-7.86, 2.83

Family Income

0.38 (0.95)

-1.50, 2.25

Parental Living Arrangements

-0.21 (2.88)

-5.85, 5.43

G

-11.78 (5.45)*

-22.46, -1.11

M*

-0.20 (0.09)*

-0.38, -0.02

G*Severity of Epilepsy

0.37 (0.23)

-0.08, 0.82

G*Sex

0.24 (0.37)

-0.49, 0.96

G*Age at Diagnosis

0.15 (0.09)

-0.03, 0.32

G*Seizure Type

0.25 (0.39)

-0.50, 1.01

G*Cognitive Problems

-0.74 (0.70)

-2.12, 0.64

G*Behavioural Problems

0.08 (0.49)

-0.88, 1.03

G*Family Income

-0.60 (0.33)

-1.24, 0.04

G*Parental Living Arrangements

1.55 (0.90)

-0.22, 3.33

*p<0.05
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Table F-4: GEE model assessing five-year seizure freedom as a mediator between the relationship of
severity of epilepsy and depressive symptoms controlling for potential demographic and clinical
confounders without multiple imputation (n=110)
Variable

Co-efficient (SE)

95% Confidence Interval

Intercept

-2.83 (7.82)

-18.15, 12.49

Severity of Epilepsy

0.84 (1.07)

-1.26, 2.94

Sex

0.67 (1.82)

-2.90, 4.25

Age at Diagnosis

0.73 (0.33)*

0.09, 1.38

Seizure Type

2.87 (1.74)

-0.54, 6.29

Cognitive Problems

-1.33 (2.62)

-6.46, 3.80

Behavioural Problems

-1.90 (2.87)

-7.53, 3.73

Family Income

-0.27 (0.92)

-2.07, 1.53

Parental Living Arrangements

0.67 (2.47)

-4.17, 5.51

G

7.11 (3.43)*

0.38, 13.84

M*

6.33 (2.18)**

2.06, 10.60

G*Severity of Epilepsy

1.34 (0.47)**

0.42, 2.25

G*Sex

-0.37 (0.56)

-1.46, 0.72

G*Age at Diagnosis

0.04 (0.12)

-0.19, 0.27

G*Seizure Type

-0.03 (0.55)

-1.11, 1.05

G*Cognitive Problems

0.94 (0.69)

-0.42, 2.29

G*Behavioural Problems

-1.32 (0.95)

-3.19, 0.55

G*Family Income

-0.07 (0.28)

-0.62, 0.48

G*Parental Living Arrangements

0.32 (0.82)

-1.30, 1.94

*p<0.05, **p<0.005
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Table F-5: GEE model assessing AED use as a mediator between the relationship of severity of epilepsy
and depressive symptoms controlling for potential demographic and clinical confounders without multiple
imputation (n=109)
Variable

Co-efficient (SE)

95% Confidence Interval

Intercept

8.81 (10.00)

-10.79, 28.42

Severity of Epilepsy

1.73 (1.10)

0.42, 3.88

Sex

-0.49 (1.82)

-4.07, 3.08

Age at Diagnosis

0.72 (0.37)*

0.00, 1.44

Seizure Type

4.06 (1.74)**

0.66, 7.46

Cognitive Problems

-0.80 (2.66)

-6.01, 4.42

Behavioural Problems

-1.90 (2.89)

-7.55, 3.76

Family Income

-0.82 (0.95)

-2.69,1.05

Parental Living Arrangements

0.88 (2.82)

-4.65, 6.42

G

-6.51 (5.89)

-18.05, 5.04

M*

-2.79 (2.49)

-7.67, 2.09

G*Severity of Epilepsy

0.49 (0.44)

-0.37, 1.35

G*Sex

0.06 (0.23)

-0.39, 0.51

G*Age at Diagnosis

0.09 (0.10)

-0.10, 0.28

G*Seizure Type

-0.33 (0.33)

-0.97, 0.32

G*Cognitive Problems

0.55 (0.56)

-0.54, 1.64

G*Behavioural Problems

-0.68 (0.72)

-2.09, 0.73

G*Family Income

0.16 (0.18)

-0.18, 0.51

G*Parental Living Arrangements

0.36 (0.41)

-0.45, 1.16

*p<0.05, **p<0.02
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